Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Flegal, 2012, Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999-2010, JAMA, 307, 491, 10.1001/jama.2012.39
Abdullah, 2010, The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies, Diabetes Res Clin Pract, 89, 309, 10.1016/j.diabres.2010.04.012
Flegal, 1998, Overweight and obesity in the United States: prevalence and trends, 1960-1994, Int J Obes Relat Metab Disord, 22, 39, 10.1038/sj.ijo.0800541
2004, Prevalence of overweight and obesity among adults with diagnosed diabetes–United States, 1988-1994 and 1999-2002, MMWR Morb Mortal Wkly Rep, 53, 1066
2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8
Defronzo, 2009, Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus, Diabetes, 58, 773, 10.2337/db09-9028
Rao Kondapally Seshasai, 2011, Diabetes mellitus, fasting glucose, and risk of cause-specific death, N Engl J Med, 364, 829, 10.1056/NEJMoa1008862
Lloyd-Jones, 2010, Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association's strategic impact goal through 2020 and beyond, Circulation, 121, 586, 10.1161/CIRCULATIONAHA.109.192703
Cornier, 2011, Assessing adiposity: a scientific statement from the American heart association, Circulation, 124, 1996, 10.1161/CIR.0b013e318233bc6a
Flint, 2010, Excess weight and the risk of incident coronary heart disease among men and women, Obesity, 18, 377, 10.1038/oby.2009.223
Lee, 2008, Indices of abdominal obesity are better discriminators of cardiovascular risk factors than bmi: a meta-analysis, J Clin Epidemiol, 61, 646, 10.1016/j.jclinepi.2007.08.012
Chusyd, 2016, Relationships between rodent white adipose fat pads and human white adipose fat depots, Front Nutr, 3, 10, 10.3389/fnut.2016.00010
Reddy, 2019, Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes, Clin Chim Acta, 496, 35, 10.1016/j.cca.2019.06.019
Freedl, 2004, Role of a critical visceral adipose tissue threshold (cvatt) in metabolic syndrome: implications for controlling dietary carbohydrates: a review, Nutr Metab., 1, 12, 10.1186/1743-7075-1-12
Kwok, 2016, Heterogeneity of white adipose tissue: molecular basis and clinical implications, Exp Mol Med, 48, e215, 10.1038/emm.2016.5
Gesta, 2006, Evidence for a role of developmental genes in the origin of obesity and body fat distribution, Proc Natl Acad Sci USA, 103, 6676, 10.1073/pnas.0601752103
Baker, 2005, Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study, Diabetes, 54, 2492, 10.2337/diabetes.54.8.2492
Ho, 1978, Formation of the epicardium studied with the scanning electron microscope, Dev Biol, 66, 579, 10.1016/0012-1606(78)90263-4
Iacobellis, 2005, Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart, Nat Clin Pract Cardiovasc Med, 2, 536, 10.1038/ncpcardio0319
Marchington, 1989, Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties, Comp Biochem Physiol B, 94, 225, 10.1016/0305-0491(89)90337-4
Mazurek, 2003, Human epicardial adipose tissue is a source of inflammatory mediators, Circulation, 108, 2460, 10.1161/01.CIR.0000099542.57313.C5
Iacobellis, 2011, Epicardial fat: from the biomolecular aspects to the clinical practice, Int J Biochem Cell Biol, 43, 1651, 10.1016/j.biocel.2011.09.006
Szasz, 2012, Perivascular adipose tissue: more than just structural support, Clin Sci, 122, 1, 10.1042/CS20110151
Qi, 2018, Perivascular adipose tissue (pvat) in atherosclerosis: a double-edged sword, Cardiovasc Diabetol, 17, 134, 10.1186/s12933-018-0777-x
Björntorp, 1990, Portal Adipose tissue as a generator of risk factors for cardiovascular disease and diabetes, Arteriosclerosis, 10, 493, 10.1161/01.ATV.10.4.493
Zhang, 2018, An adipose tissue atlas: an image-guided identification of human-like bat and beige depots in rodents, Cell Metab, 27, 252, 10.1016/j.cmet.2017.12.004
Cannon, 2004, Brown adipose tissue: function and physiological significance, Physiol Rev, 84, 277, 10.1152/physrev.00015.2003
Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, N Engl J Med, 360, 1509, 10.1056/NEJMoa0810780
Cypess, 2015, Activation of human brown adipose tissue by a β3-adrenergic receptor agonist, Cell Metab, 21, 33, 10.1016/j.cmet.2014.12.009
Cypess, 2013, Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat, Nat Med, 19, 635, 10.1038/nm.3112
Kahn, 2019, Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome, J Clin Invest, 129, 3990, 10.1172/JCI129187
Hany, 2002, Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region, Eur J Nucl Med Mol Imaging, 29, 1393, 10.1007/s00259-002-0902-6
Lee, 2019, Adipose tissue-derived signatures for obesity and type 2 diabetes: adipokines, batokines and micrornas, J Clin Med, 8, E854, 10.3390/jcm8060854
Srivastava, 2019, Brown and brite: the fat soldiers in the anti-obesity fight, Front Physiol, 10, 38, 10.3389/fphys.2019.00038
Waldén, 2012, Recruited vs. Nonrecruited molecular signatures of brown, Brite, and white adipose tissues, Am J Physiol Endocrinol Metab, 302, E19, 10.1152/ajpendo.00249.2011
Wu, 2012, Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human, Cell, 150, 366, 10.1016/j.cell.2012.05.016
Jespersen, 2013, A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans, Cell Metab, 17, 798, 10.1016/j.cmet.2013.04.011
Sharp, 2012, Human bat possesses molecular signatures that resemble beige/brite cells, PLoS ONE, 7, e49452, 10.1371/journal.pone.0049452
Shinoda, 2015, Genetic and functional characterization of clonally derived adult human brown adipocytes, Nat Med, 21, 389, 10.1038/nm.3819
Zuriaga, 2017, Humans and mice display opposing patterns of Browning Gene expression in visceral and subcutaneous white adipose tissue depots, Front Cardiovasc Med, 4, 27, 10.3389/fcvm.2017.00027
Kir, 2014, Tumour-derived pth-related protein triggers adipose tissue browning and cancer cachexia, Nature, 513, 100, 10.1038/nature13528
Neinast, 2015, Activation of natriuretic peptides and the sympathetic nervous system following roux-en-y gastric bypass is associated with gonadal adipose tissues browning, Mol Metab, 4, 427, 10.1016/j.molmet.2015.02.006
Sidossis, 2015, Browning of subcutaneous white adipose tissue in humans after severe adrenergic stress, Cell Metab, 22, 219, 10.1016/j.cmet.2015.06.022
den Hartigh, 2017, Metabolically distinct weight loss by 10,12 cla and caloric restriction highlight the importance of subcutaneous white adipose tissue for glucose homeostasis in mice, PLoS ONE, 12, e0172912, 10.1371/journal.pone.0172912
Sahuri-Arisoylu, 2016, Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate, Int J Obes, 40, 955, 10.1038/ijo.2016.23
Ghorbani, 1997, Appearance of brown adipocytes in white adipose tissue during cl 316,243-induced reversal of obesity and diabetes in zucker fa/fa rats, Int J Obes Relat Metab Disord, 21, 465, 10.1038/sj.ijo.0800432
Baskaran, 2016, Capsaicin induces browning of white adipose tissue and counters obesity by activating trpv1 channel-dependent mechanisms, Br J Pharmacol, 173, 2369, 10.1111/bph.13514
Chen, 2017, Green tea extract induces genes related to browning of white adipose tissue and limits weight-gain in high energy diet-fed rat, Food Nutr Res, 61, 1347480, 10.1080/16546628.2017.1347480
Petrovic, 2010, Chronic peroxisome proliferator-activated receptor gamma (ppargamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, ucp1-containing adipocytes molecularly distinct from classic brown adipocytes, J Biol Chem, 285, 7153, 10.1074/jbc.M109.053942
Lin, 2012, Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms, PLoS ONE, 7, e35240, 10.1371/journal.pone.0035240
Fukui, 2000, A new thiazolidinedione, nc-2100, which is a weak ppar-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of kkay obese mice, Diabetes, 49, 759, 10.2337/diabetes.49.5.759
Stanford, 2015, Exercise effects on white adipose tissue: beiging and metabolic adaptations, Diabetes, 64, 2361, 10.2337/db15-0227
Seale, 2008, Prdm16 controls a brown fat/skeletal muscle switch, Nature, 454, 961, 10.1038/nature07182
Barbatelli, 2010, The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation, Am J Physiol Endocrinol Metab, 298, E1244, 10.1152/ajpendo.00600.2009
Cinti, 2009, Transdifferentiation properties of adipocytes in the adipose organ, Am J Physiol Endocrinol Metab, 297, E977, 10.1152/ajpendo.00183.2009
Altshuler-Keylin, 2016, Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance, Cell Metab, 24, 402, 10.1016/j.cmet.2016.08.002
Xue, 2015, Clonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytes, Nat Med, 21, 760, 10.1038/nm.3881
Guerra, 1998, Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity, J Clin Invest, 102, 412, 10.1172/JCI3155
Almind, 2004, Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice, Diabetes, 53, 3274, 10.2337/diabetes.53.12.3274
Collins, 1997, Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice, Endocrinology, 138, 405, 10.1210/endo.138.1.4829
Seale, 2011, Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice, J Clin Invest, 121, 96, 10.1172/JCI44271
Shao, 2016, Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program, Cell Metab, 23, 1167, 10.1016/j.cmet.2016.04.023
Qatanani, 2007, Mechanisms of obesity-associated insulin resistance: many choices on the menu, Genes Dev, 21, 1443, 10.1101/gad.1550907
Schoettl, 2018, Heterogeneity of adipose tissue in development and metabolic function, J Exp Biol, 221, jeb162958, 10.1242/jeb.162958
Chondronikola, 2016, Brown adipose tissue is linked to a distinct thermoregulatory response to mild cold in people, Front Physiol, 7, 129, 10.3389/fphys.2016.00129
Frontini, 2010, Distribution and development of brown adipocytes in the murine and human adipose organ, Cell Metab, 11, 253, 10.1016/j.cmet.2010.03.004
Yoneshiro, 2013, Recruited brown adipose tissue as an antiobesity agent in humans, J Clin Invest, 123, 3404, 10.1172/JCI67803
Harms, 2013, Brown and beige fat: development, function and therapeutic potential, Nat Med, 19, 1252, 10.1038/nm.3361
Nguyen, 2011, Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis, Nature, 480, 104, 10.1038/nature10653
Qiu, 2014, Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat, Cell, 157, 1292, 10.1016/j.cell.2014.03.066
Shan, 2017, The metabolic er stress sensor ire1α suppresses alternative activation of macrophages and impairs energy expenditure in obesity, Nat Immunol, 18, 519, 10.1038/ni.3709
Vargovic, 2016, Continuous cold exposure induces an anti-inflammatory response in mesenteric adipose tissue associated with catecholamine production and thermogenin expression in rats, Endocr Regul, 50, 137, 10.1515/enr-2016-0015
Liu, 2015, Injecting engineered anti-inflammatory macrophages therapeutically induces white adipose tissue browning and improves diet-induced insulin resistance, Adipocyte, 4, 123, 10.4161/21623945.2014.981438
Liu, 2014, Reducing rip140 expression in macrophage alters atm infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance, Diabetes, 63, 4021, 10.2337/db14-0619
Kusminski, 2012, Mitoneet-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity, Nat Med, 18, 1539, 10.1038/nm.2899
Hallowell, 2017, Mtorc2 signalling regulates m2 macrophage differentiation in response to helminth infection and adaptive thermogenesis, Nat Commun, 8, 14208, 10.1038/ncomms14208
Brestoff, 2015, Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity, Nature, 519, 242, 10.1038/nature14115
Lee, 2015, Activated type 2 innate lymphoid cells regulate beige fat biogenesis, Cell, 160, 74, 10.1016/j.cell.2014.12.011
Fischer, 2017, Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis, Nat Med, 23, 623, 10.1038/nm.4316
Ahima, 2008, Adipokines and the peripheral and neural control of energy balance, Mol Endocrinol, 22, 1023, 10.1210/me.2007-0529
Farooqi, 2014, 20 years of leptin: human disorders of leptin action, J Endocrinol, 223, T63, 10.1530/JOE-14-0480
Considine, 1996, Serum immunoreactive-leptin concentrations in normal-weight and obese humans, N Engl J Med, 334, 292, 10.1056/NEJM199602013340503
Boden, 1996, Effect of fasting on serum leptin in normal human subjects, J Clin Endocrinol Metab, 81, 3419, 10.1210/jcem.81.9.8784108
Hube, 1996, Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans, Horm Metab Res, 28, 690, 10.1055/s-2007-979879
Hu, 1996, Adipoq is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697
Maeda, 1996, Cdna cloning and expression of a novel adipose specific collagen-like factor, apm1 (adipose most abundant gene transcript 1), Biochem Biophys Res Commun, 221, 286, 10.1006/bbrc.1996.0587
Nakano, 1996, Isolation and characterization of gbp28, a novel gelatin-binding protein purified from human plasma, J Biochem, 120, 803, 10.1093/oxfordjournals.jbchem.a021483
Scherer, 1995, A novel serum protein similar to c1q, produced exclusively in adipocytes, J Biol Chem, 270, 26746, 10.1074/jbc.270.45.26746
Cnop, 2003, Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex, Diabetologia, 46, 459, 10.1007/s00125-003-1074-z
Kern, 2003, Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression, Diabetes, 52, 1779, 10.2337/diabetes.52.7.1779
Kishida, 2011, Relationships between circulating adiponectin levels and fat distribution in obese subjects, J Atheroscler Thromb, 18, 592, 10.5551/jat.7625
Samaras, 2010, Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes, Obesity, 18, 884, 10.1038/oby.2009.443
Lihn, 2004, Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects, Mol Cell Endocrinol, 219, 9, 10.1016/j.mce.2004.03.002
Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/acrp30, Nat Med, 8, 731, 10.1038/nm724
Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J Clin Invest, 117, 2621, 10.1172/JCI31021
Yamauchi, 2003, cloning of adiponectin receptors that mediate antidiabetic metabolic effects, Nature, 423, 762, 10.1038/nature01705
Ye, 2015, Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets, Endocrinology, 156, 2019, 10.1210/en.2015-1066
Mandal, 2011, Molecular mechanism for adiponectin-dependent m2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin, J Biol Chem, 286, 13460, 10.1074/jbc.M110.204644
Caligiuri, 2008, Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells, Hepatology, 47, 668, 10.1002/hep.21995
Jamaluddin, 2012, Resistin: functional roles and therapeutic considerations for cardiovascular disease, Br J Pharmacol, 165, 622, 10.1111/j.1476-5381.2011.01369.x
Savage, 2001, Resistin / fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans, Diabetes, 50, 2199, 10.2337/diabetes.50.10.2199
Tsiotra, 2008, Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women, Mediators Inflamm, 2008, 892864, 10.1155/2008/892864
Ghosh, 2003, The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications, Gene, 305, 27, 10.1016/S0378-1119(02)01213-1
Sheng, 2008, Resistin is expressed in human hepatocytes and induces insulin resistance, Endocrine, 33, 135, 10.1007/s12020-008-9065-y
Yannakoulia, 2003, Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans, J Clin Endocrinol Metab, 88, 1730, 10.1210/jc.2002-021604
Degawa-Yamauchi, 2003, Serum resistin (fizz3) protein is increased in obese humans, J Clin Endocrinol Metab, 88, 5452, 10.1210/jc.2002-021808
McTernan, 2002, Resistin, central obesity, and type 2 diabetes, Lancet, 359, 46, 10.1016/S0140-6736(02)07281-1
McTernan, 2002, Increased resistin gene and protein expression in human abdominal adipose tissue, J Clin Endocrinol Metab, 87, 2407, 10.1210/jcem.87.5.8627
Valsamakis, 2004, Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines, Metabolism, 53, 430, 10.1016/j.metabol.2003.11.022
Way, 2001, Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists, J Biol Chem, 276, 25651, 10.1074/jbc.C100189200
Janke, 2002, Resistin gene expression in human adipocytes is not related to insulin resistance, Obes Res, 10, 1, 10.1038/oby.2002.1
Vidal-Puig, 2001, Resistin: a new link between obesity and insulin resistance?, Clin Endocrinol, 55, 437, 10.1046/j.1365-2265.2001.01377.x
Bokarewa, 2005, Resistin, an adipokine with potent proinflammatory properties, J Immunol, 174, 5789, 10.4049/jimmunol.174.9.5789
Yang, 2006, Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action, Am J Physiol Endocrinol Metab, 290, E1253, 10.1152/ajpendo.00572.2004
Landecho, 2019, Relevance of leptin and other adipokines in obesity-associated cardiovascular risk, Nutrients, 11, 2664, 10.3390/nu11112664
Schäffler, 2005, Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue, Biochim Biophys Acta, 1732, 96, 10.1016/j.bbaexp.2005.11.005
Auguet, 2011, New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women, BMC Med Genet, 12, 60, 10.1186/1471-2350-12-60
de Souza Batista, 2007, Omentin plasma levels and gene expression are decreased in obesity, Diabetes, 56, 1655, 10.2337/db06-1506
Pan, 2010, Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes, Diabetes Res Clin Pract, 88, 29, 10.1016/j.diabres.2010.01.013
Tan, 2008, Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose, Diabetes, 57, 801, 10.2337/db07-0990
Cai, 2009, [Expression of omentin in adipose tissues in obese and type 2 diabetic patients], Zhonghua Yi Xue Za Zhi, 89, 381
Elsaid, 2018, Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters, J Clin Transl Endocrinol, 13, 14, 10.1016/j.jcte.2018.05.003
Zhang, 2017, Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome, Acta Paediatr, 106, 1851, 10.1111/apa.14026
Moreno-Navarrete, 2010, Circulating omentin concentration increases after weight loss, Nutr Metab, 7, 27, 10.1186/1743-7075-7-27
Yamawaki, 2011, Omentin, a novel adipocytokine inhibits tnf-induced vascular inflammation in human endothelial cells, Biochem Biophys Res Commun, 408, 339, 10.1016/j.bbrc.2011.04.039
Kazama, 2012, Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells, Eur J Pharmacol, 686, 116, 10.1016/j.ejphar.2012.04.033
Kazama, 2014, A novel adipocytokine, omentin, inhibits platelet-derived growth factor-bb-induced vascular smooth muscle cell migration through antioxidative mechanism, Am J Physiol Heart Circ Physiol, 306, H1714, 10.1152/ajpheart.00048.2014
Wang, 2019, Omentin-1 attenuates lipopolysaccharide (LPS)-induced U937 macrophages activation by inhibiting the TLR4/MyD88/NF-κB signaling, Arch Biochem Biophys, 679, 108187, 10.1016/j.abb.2019.108187
Kazama, 2015, Adipocytokine, omentin inhibits doxorubicin-induced h9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species, Biochem Biophys Res Commun, 457, 602, 10.1016/j.bbrc.2015.01.032
Fernández-Trasancos, 2017, Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells, Obesity, 25, 1042, 10.1002/oby.21832
Zabetian-Targhi, 2016, Modulatory role of omentin-1 in inflammation: cytokines and dietary intake, J Am Coll Nutr, 35, 670, 10.1080/07315724.2015.1126207
Shibata, 2012, Omentin as a novel biomarker of metabolic risk factors, Diabetol Metab Syndr, 4, 37, 10.1186/1758-5996-4-37
Cuevas-Ramos, 2009, The role of fibroblast growth factor 21 (fgf21) on energy balance, glucose and lipid metabolism, Curr Diabetes Rev, 5, 216, 10.2174/157339909789804396
Coskun, 2008, Fibroblast growth factor 21 corrects obesity in mice, Endocrinology, 149, 6018, 10.1210/en.2008-0816
Markan, 2014, Circulating fgf21 is liver derived and enhances glucose uptake during refeeding and overfeeding, Diabetes, 63, 4057, 10.2337/db14-0595
BonDurant, 2017, Fgf21 regulates metabolism through adipose-dependent and -independent mechanisms, Cell Metab, 25, 935, 10.1016/j.cmet.2017.03.005
Talukdar, 2016, A long-acting fgf21 molecule, pf-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects, Cell Metab, 23, 427, 10.1016/j.cmet.2016.02.001
Izumiya, 2008, fgf21 is an akt-regulated myokine, FEBS Lett, 582, 3805, 10.1016/j.febslet.2008.10.021
Lin, 2017, metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues, Biomed Rep, 6, 495, 10.3892/br.2017.890
Zhang, 2008, Serum fgf21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans, Diabetes, 57, 1246, 10.2337/db07-1476
Fisher, 2010, Obesity is a fibroblast growth factor 21 (fgf21)-resistant state, Diabetes, 59, 2781, 10.2337/db10-0193
Crujeiras, 2017, Plasma fgf21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?, Int J Obes, 41, 1570, 10.1038/ijo.2017.138
Berti, 2015, Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes, Mol Metab, 4, 519, 10.1016/j.molmet.2015.04.002
Mashili, 2018, Adiposity is a key correlate of circulating fibroblast growth factor-21 levels in African males with or without type 2 diabetes mellitus, J Obes, 2018, 7461903, 10.1155/2018/7461903
Sandoval, 2018, Mediterranean tomato-based sofrito sauce improves fibroblast growth factor 21 (fgf21) signaling in white adipose tissue of obese zucker rats, Mol Nutr Food Res, 62, 1, 10.1002/mnfr.201700606
Fon Tacer, 2010, Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse, Mol Endocrinol, 24, 2050, 10.1210/me.2010-0142
Muise, 2008, Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states, Mol Pharmacol, 74, 403, 10.1124/mol.108.044826
Miehle, 2016, Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy, Cytokine, 83, 239, 10.1016/j.cyto.2016.04.015
Keipert, 2015, Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of fgf21 secretion, Mol Metab, 4, 537, 10.1016/j.molmet.2015.04.006
Gerhard, 2014, Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity, Int J Obes, 38, 371, 10.1038/ijo.2013.152
van Baak, 2019, Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity, Int J Obes, 44, 544, 10.1038/s41366-019-0433-x
Hong, 2019, Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes, BMJ Open Diabetes Res Care, 7, e000776, 10.1136/bmjdrc-2019-000776
Mraz, 2009, Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity, Clin Endocrinol, 71, 369, 10.1111/j.1365-2265.2008.03502.x
Kotulák, 2011, Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance, Physiol Res, 60, 757, 10.33549/physiolres.932134
Lee, 2018, Clinical implications of ucp1 mRNA expression in human cervical adipose tissue under physiological conditions, Obesity, 26, 1008, 10.1002/oby.22188
Lee, 2014, Functional thermogenic beige adipogenesis is inducible in human neck fat, Int J Obes, 38, 170, 10.1038/ijo.2013.82
Vargas, 2018, Thermogenic capacity of human periaortic adipose tissue is transformed by body weight, PLoS ONE, 13, e0194269, 10.1371/journal.pone.0194269
Vargas, 2017, Functional characterization of preadipocytes derived from human periaortic adipose tissue, Int J Endocrinol, 2017, 2945012, 10.1155/2017/2945012
Cuevas-Ramos, 2010, Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels, Eur J Endocrinol, 163, 469, 10.1530/EJE-10-0454
Gómez-Sámano, 2017, Fibroblast growth factor 21 and its novel association with oxidative stress, Redox Biol, 11, 335, 10.1016/j.redox.2016.12.024
Hondares, 2011, Thermogenic activation induces fgf21 expression and release in brown adipose tissue, J Biol Chem, 286, 12983, 10.1074/jbc.M110.215889
Goossens, 2015, Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen?, Front Endocrinol, 6, 55, 10.3389/fendo.2015.00055
Wang, 2014, The adipochaser mouse: a model tracking adipogenesis in vivo, Adipocyte, 3, 146, 10.4161/adip.27656
Wang, 2013, Tracking adipogenesis during white adipose tissue development, expansion and regeneration, Nat Med, 19, 1338, 10.1038/nm.3324
Kim, 2014, Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance, Cell Metab, 20, 1049, 10.1016/j.cmet.2014.10.010
Guillermier, 2017, Imaging mass spectrometry demonstrates age-related decline in human adipose plasticity, JCI Insight, 2, e90349, 10.1172/jci.insight.90349
Denis, 2013, ‘Metabolically healthy obesity': origins and implications, Mol Aspects Med, 34, 59, 10.1016/j.mam.2012.10.004
Stefan, 2013, Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications, Lancet Diabetes Endocrinol, 1, 152, 10.1016/S2213-8587(13)70062-7
Samocha-Bonet, 2014, Metabolically healthy and unhealthy obese–the 2013 stock conference report, Obes Rev, 15, 697, 10.1111/obr.12199
Smith, 2019, Metabolically healthy obesity: facts and fantasies, J Clin Invest, 129, 3978, 10.1172/JCI129186
Naukkarinen, 2014, Characterising metabolically healthy obesity in weight-discordant monozygotic twins, Diabetologia, 57, 167, 10.1007/s00125-013-3066-y
Rey-López, 2014, The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used, Obes Rev, 15, 781, 10.1111/obr.12198
Karelis, 2005, The metabolically healthy but obese individual presents a favorable inflammation profile, J Clin Endocrinol Metab, 90, 4145, 10.1210/jc.2005-0482
Blüher, 2010, The distinction of metabolically ‘healthy' from ‘unhealthy' obese individuals, Curr Opin Lipidol, 21, 38, 10.1097/MOL.0b013e3283346ccc
Echouffo-Tcheugui, 2019, Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the framingham heart study, J Clin Endocrinol Metab, 104, 738, 10.1210/jc.2018-01321
Mongraw-Chaffin, 2018, Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk, J Am Coll Cardiol, 71, 1857, 10.1016/j.jacc.2018.02.055
Soriguer, 2013, Metabolically healthy but obese, a matter of time? Findings from the prospective pizarra study, J Clin Endocrinol Metab, 98, 2318, 10.1210/jc.2012-4253
Kouvari, 2019, Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the attica cohort study, Metabolism, 93, 18, 10.1016/j.metabol.2019.01.003
Caleyachetty, 2017, Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women, J Am Coll Cardiol, 70, 1429, 10.1016/j.jacc.2017.07.763
Twig, 2014, Diabetes risk among overweight and obese metabolically healthy young adults, Diabetes Care, 37, 2989, 10.2337/dc14-0869
Guo, 2014, The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity, Obesity, 22, 110, 10.1002/oby.20585
Johnson, 2019, Do worse baseline risk factors explain the association of healthy obesity with increased mortality risk? Whitehall II study, Int J Obes, 43, 1578, 10.1038/s41366-018-0192-0
Shin, 2006, Weight loss effect on inflammation and ldl oxidation in metabolically healthy but obese (mho) individuals: low inflammation and ldl oxidation in mho women, Int J Obes, 30, 1529, 10.1038/sj.ijo.0803304
Karelis, 2008, Metabolically healthy but obese women: effect of an energy-restricted diet, Diabetologia, 51, 1752, 10.1007/s00125-008-1038-4
Kantartzis, 2011, Effects of a lifestyle intervention in metabolically benign and malign obesity, Diabetologia, 54, 864, 10.1007/s00125-010-2006-3
Blüher, 2014, Are metabolically healthy obese individuals really healthy?, Eur J Endocrinol, 171, R209, 10.1530/EJE-14-0540
Yang, 2007, Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?, Diabetologia, 50, 1127, 10.1007/s00125-007-0640-1
Yki-Järvinen, 2014, Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome, Lancet Diabetes Endocrinol, 2, 901, 10.1016/S2213-8587(14)70032-4
Ruderman, 1981, The Metabolically-Obese, Normal-weight individual, Am J Clin Nutr, 34, 1617, 10.1093/ajcn/34.8.1617
Newell-Morris, 1989, Fatness, fat distribution, and glucose tolerance in second-generation Japanese-American (nisei) men, Am J Clin Nutr, 50, 9, 10.1093/ajcn/50.1.9
Jensen, 2006, Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model, Obesity, 14, 20S, 10.1038/oby.2006.278
Karpe, 2015, Biology of upper-body and lower-body adipose tissue–link to whole-body phenotypes, Nat Rev Endocrinol, 11, 90, 10.1038/nrendo.2014.185
Vega, 2006, Influence of body fat content and distribution on variation in metabolic risk, J Clin Endocrinol Metab, 91, 4459, 10.1210/jc.2006-0814
Søndergaard, 2012, Body composition determines direct ffa storage pattern in overweight women, Am J Physiol Endocrinol Metab, 302, E1599, 10.1152/ajpendo.00015.2012
Jensen, 2008, Role of body fat distribution and the metabolic complications of obesity, J Clin Endocrinol Metab, 93, S57, 10.1210/jc.2008-1585
Fu, 2018, Circulating osteonectin and adipokine profiles in relation to metabolically healthy obesity in Chinese children: findings from bcams, J Am Heart Assoc, 7, e009169, 10.1161/JAHA.118.009169
Klöting, 2010, Insulin-sensitive obesity, Am J Physiol Endocrinol Metab, 299, E506, 10.1152/ajpendo.00586.2009
Straznicky, 2009, Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome, Am J Clin Nutr, 89, 27, 10.3945/ajcn.2008.26299
Genelhu, 2009, Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes, Eur J Intern Med, 20, 289, 10.1016/j.ejim.2008.09.009
Ahl, 2015, Adiponectin levels differentiate metabolically healthy vs unhealthy among obese and nonobese white individuals, J Clin Endocrinol Metab, 100, 4172, 10.1210/jc.2015-2765
Weiss, 2005, The Obese insulin-sensitive adolescent: importance of adiponectin and lipid partitioning, J Clin Endocrinol Metab, 90, 3731, 10.1210/jc.2004-2305
Indulekha, 2015, Metabolic obesity, adipocytokines, and inflammatory markers in asian indians–cures-124, Diabetes Technol Ther, 17, 134, 10.1089/dia.2014.0202
Doumatey, 2012, Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (mho) phenotype in African Americans, J Endocrinol Metab, 2, 51, 10.4021/jem95w
Alizadeh, 2017, Circulating omentin-1 might be associated with metabolic health status in different phenotypes of body size, Arch Endocrinol Metab, 61, 567, 10.1590/2359-3997000000269
Bremer, 2013, Adipose tissue dysfunction in nascent metabolic syndrome, J Obes, 2013, 393192, 10.1155/2013/393192
Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451
Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246
Han, 2007, Adipocyte-derived serum amyloid a3 and hyaluronan play a role in monocyte recruitment and adhesion, Diabetes, 56, 2260, 10.2337/db07-0218
Haase, 2014, Local proliferation of macrophages in adipose tissue during obesity-induced inflammation, Diabetologia, 57, 562, 10.1007/s00125-013-3139-y
Bourlier, 2008, Remodeling phenotype of human subcutaneous adipose tissue macrophages, Circulation, 117, 806, 10.1161/CIRCULATIONAHA.107.724096
Cancello, 2006, Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity, Diabetes, 55, 1554, 10.2337/db06-0133
Subramanian, 2008, Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese ldl receptor-deficient mice, Arterioscler Thromb Vasc Biol, 28, 685, 10.1161/ATVBAHA.107.157685
Murano, 2008, Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice, J Lipid Res, 49, 1562, 10.1194/jlr.M800019-JLR200
Harman-Boehm, 2007, Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity, J Clin Endocrinol Metab, 92, 2240, 10.1210/jc.2006-1811
Lumeng, 2007, Obesity induces a phenotypic switch in adipose tissue macrophage polarization, J Clin Invest, 117, 175, 10.1172/JCI29881
Wentworth, 2010, Pro-inflammatory cd11c+cd206+ adipose tissue macrophages are associated with insulin resistance in human obesity, Diabetes, 59, 1648, 10.2337/db09-0287
Lumeng, 2007, Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity, Diabetes, 56, 16, 10.2337/db06-1076
Morris, 2011, Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states, Curr Opin Clin Nutr Metab Care, 14, 341, 10.1097/MCO.0b013e328347970b
Kratz, 2014, Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages, Cell Metab, 20, 614, 10.1016/j.cmet.2014.08.010
Winer, 2009, Normalization of obesity-associated insulin resistance through immunotherapy, Nat Med, 15, 921, 10.1038/nm.2001
O'Rourke, 2009, Depot-specific differences in inflammatory mediators and a role for nk cells and ifn-gamma in inflammation in human adipose tissue, Int J Obes, 33, 978, 10.1038/ijo.2009.133
Rocha, 2008, Interferon-gamma, a th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity, Circ Res, 103, 467, 10.1161/CIRCRESAHA.108.177105
Bendelac, 2007, The biology of nkt cells, Annu Rev Immunol, 25, 297, 10.1146/annurev.immunol.25.022106.141711
Kronenberg, 2005, Toward an understanding of nkt cell biology: progress and paradoxes, Annu Rev Immunol, 23, 877, 10.1146/annurev.immunol.23.021704.115742
Ji, 2012, Activation of natural killer t cells promotes m2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (il-4)/stat6 protein signaling axis in obesity, J Biol Chem, 287, 13561, 10.1074/jbc.M112.350066
Lynch, 2012, Adipose tissue invariant nkt cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production, Immunity, 37, 574, 10.1016/j.immuni.2012.06.016
Lynch, 2009, Invariant nkt cells and cd1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity, Eur J Immunol, 39, 1893, 10.1002/eji.200939349
Schipper, 2012, Natural killer t cells in adipose tissue prevent insulin resistance, J Clin Invest, 122, 3343, 10.1172/JCI62739
Winer, 2011, B cells promote insulin resistance through modulation of t cells and production of pathogenic igg antibodies, Nat Med, 17, 610, 10.1038/nm.2353
Liu, 2009, Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice, Nat Med, 15, 940, 10.1038/nm.1994
Cho, 2016, Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance, J Immunol, 197, 3650, 10.4049/jimmunol.1600820
Mortensen, 2001, C-reactive protein, inflammation, and innate immunity, Immunol Res, 24, 163, 10.1385/IR:24:2:163
Yudkin, 2000, Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?, Atherosclerosis, 148, 209, 10.1016/S0021-9150(99)00463-3
Schmidt-Arras, 2016, Il-6 pathway in the liver: from physiopathology to therapy, J Hepatol, 64, 1403, 10.1016/j.jhep.2016.02.004
Visser, 1999, Elevated c-reactive protein levels in overweight and obese adults, JAMA, 282, 2131, 10.1001/jama.282.22.2131
Yang, 2006, Acute-phase serum amyloid a: an inflammatory adipokine and potential link between obesity and its metabolic complications, PLoS Med, 3, e287, 10.1371/journal.pmed.0030287
Uemura, 2017, Relationships of serum high-sensitivity c-reactive protein and body size with insulin resistance in a japanese cohort, PLoS ONE, 12, e0178672, 10.1371/journal.pone.0178672
González, 2006, Metabolic syndrome, insulin resistance and the inflammation markers c-reactive protein and ferritin, Eur J Clin Nutr, 60, 802, 10.1038/sj.ejcn.1602384
Cozlea, 2013, The impact of c reactive protein on global cardiovascular risk on patients with coronary artery disease, Curr Health Sci J, 39, 225
Filippin-Monteiro, 2012, Serum amyloid a is a growth factor for 3t3-l1 adipocytes, inhibits differentiation and promotes insulin resistance, Int J Obes, 36, 1032, 10.1038/ijo.2011.193
Johnson, 2004, Serum amyloid a as a predictor of coronary artery disease and cardiovascular outcome in women: The national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation (wise), Circulation, 109, 726, 10.1161/01.CIR.0000115516.54550.B1
Targonska-Stepniak, 2014, Serum amyloid a as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis, Mediators Inflamm, 2014, 793628, 10.1155/2014/793628
Getz, 2016, Serum amyloid a and atherosclerosis, Curr Opin Lipidol, 27, 531, 10.1097/MOL.0000000000000331
Lewis, 2004, Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice, Circulation, 110, 540, 10.1161/01.CIR.0000136819.93989.E1
Meek, 1994, Expression of apolipoprotein serum amyloid a mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid a function, Proc Natl Acad Sci USA, 91, 3186, 10.1073/pnas.91.8.3186
Bastard, 2000, Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss, J Clin Endocrinol Metab, 85, 3338, 10.1210/jcem.85.9.6839
Pickup, 2000, Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes, Life Sci, 67, 291, 10.1016/S0024-3205(00)00622-6
Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo, J Clin Endocrinol Metab, 82, 4196, 10.1210/jc.82.12.4196
Yeop Han, 2010, Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation, Diabetes, 59, 386, 10.2337/db09-0925
Zhang, 2014, Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity, J Biol Chem, 289, 32178, 10.1074/jbc.M114.601096
Matsubara, 2012, Pgrn is a key adipokine mediating high fat diet-induced insulin resistance and obesity through il-6 in adipose tissue, Cell Metab, 15, 38, 10.1016/j.cmet.2011.12.002
Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, 847, 10.1210/jc.83.3.847
Carey, 1996, Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of niddm, Diabetes, 45, 633, 10.2337/diabetes.45.5.633
Sabio, 2008, A stress signaling pathway in adipose tissue regulates hepatic insulin resistance, Science, 322, 1539, 10.1126/science.1160794
Rotter, 2003, Interleukin-6 (Il-6) induces insulin resistance in 3t3-l1 adipocytes and is, like il-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects, J Biol Chem, 278, 45777, 10.1074/jbc.M301977200
Wunderlich, 2010, Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action, Cell Metab, 12, 237, 10.1016/j.cmet.2010.06.011
Braune, 2017, Il-6 regulates m2 polarization and local proliferation of adipose tissue macrophages in obesity, J Immunol, 198, 2927, 10.4049/jimmunol.1600476
Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183
Kern, 2001, Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance, Am J Physiol Endocrinol Metab, 280, E745, 10.1152/ajpendo.2001.280.5.E745
Zahorska-Markiewicz, 2000, Serum concentrations of tnf-alpha and soluble tnf-alpha receptors in obesity, Int J Obes Relat Metab Disord, 24, 1392, 10.1038/sj.ijo.0801398
Zahorska-Markiewicz, 2006, Metabolic effects associated with adipose tissue distribution, Adv Med Sci, 51, 111
Paz, 1997, A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of irs-1 and irs-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation, J Biol Chem, 272, 29911, 10.1074/jbc.272.47.29911
Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 112, 1785, 10.1172/JCI20514
Weisberg, 2006, Ccr2 modulates inflammatory and metabolic effects of high-fat feeding, J Clin Invest, 116, 115, 10.1172/JCI24335
Christiansen, 2005, Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects, Int J Obes, 29, 146, 10.1038/sj.ijo.0802839
Kanda, 2006, Mcp-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J Clin Invest, 116, 1494, 10.1172/JCI26498
Sartipy, 2003, Monocyte chemoattractant protein 1 in obesity and insulin resistance, Proc Natl Acad Sci USA, 100, 7265, 10.1073/pnas.1133870100
Bruun, 2005, Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (at): implication of macrophages resident in the at, J Clin Endocrinol Metab, 90, 2282, 10.1210/jc.2004-1696
Poitou, 2005, Serum amyloid a: production by human white adipocyte and regulation by obesity and nutrition, Diabetologia, 48, 519, 10.1007/s00125-004-1654-6
Poitou, 2006, Serum amyloid a: a marker of adiposity-induced low-grade inflammation but not of metabolic status, Obesity, 14, 309, 10.1038/oby.2006.40
Lappalainen, 2008, Serum concentrations and expressions of serum amyloid a and leptin in adipose tissue are interrelated: the genobin study, Eur J Endocrinol, 158, 333, 10.1530/EJE-07-0598
Trayhurn, 2004, Adipokines: inflammation and the pleiotropic role of white adipose tissue, Br J Nutr, 92, 347, 10.1079/BJN20041213
Gómez-Ambrosi, 2006, Increased serum amyloid a concentrations in morbid obesity decrease after gastric bypass, Obes Surg, 16, 262, 10.1381/096089206776116525
den Hartigh, 2014, Deletion of serum amyloid a3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice, PLoS ONE, 9, e108564, 10.1371/journal.pone.0108564
Sjöholm, 2005, A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid a, J Clin Endocrinol Metab, 90, 2233, 10.1210/jc.2004-1830
Krssak, 1999, Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1h nmr spectroscopy study, Diabetologia, 42, 113, 10.1007/s001250051123
Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/edrv.21.6.0415
Yu, 2002, Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (irs-1)-associated phosphatidylinositol 3-kinase activity in muscle, J Biol Chem, 277, 50230, 10.1074/jbc.M200958200
Itani, 2002, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase c, and ikappab-alpha, Diabetes, 51, 2005, 10.2337/diabetes.51.7.2005
Turinsky, 1990, 1,2-diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo, J Biol Chem, 265, 16880, 10.1016/S0021-9258(17)44844-7
Holl, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance, Cell Metab, 5, 167, 10.1016/j.cmet.2007.01.002
Fabbrini, 2009, Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity, Proc Natl Acad Sci USA, 106, 15430, 10.1073/pnas.0904944106
Korenblat, 2008, Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects, Gastroenterology, 134, 1369, 10.1053/j.gastro.2008.01.075
Magkos, 2010, Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction, Obesity, 18, 1510, 10.1038/oby.2010.90
Kabir, 2005, Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance, Am J Physiol Endocrinol Metab, 288, E454, 10.1152/ajpendo.00203.2004
Donnelly, 2005, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, 115, 1343, 10.1172/JCI23621
Perry, 2014, The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes, Nature, 510, 84, 10.1038/nature13478
Stratford, 2004, Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of akt/protein kinase b, J Biol Chem, 279, 36608, 10.1074/jbc.M406499200
Blouin, 2010, Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling, Diabetes, 59, 600, 10.2337/db09-0897
Xia, 2015, Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis, Cell Metab, 22, 266, 10.1016/j.cmet.2015.06.007
Liu, 2012, Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism, Proc Natl Acad Sci USA, 109, 14568, 10.1073/pnas.1211611109
Ruan, 2016, Adiponectin signaling and function in insulin target tissues, J Mol Cell Biol, 8, 101, 10.1093/jmcb/mjw014
Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating amp-activated protein kinase, Nat Med, 8, 1288, 10.1038/nm788
Bézaire, 2009, Chronic tnfalpha and camp pre-treatment of human adipocytes alter hsl, atgl and perilipin to regulate basal and stimulated lipolysis, FEBS Lett, 583, 3045, 10.1016/j.febslet.2009.08.019
Laurencikiene, 2007, Nf-kappab is important for tnf-alpha-induced lipolysis in human adipocytes, J Lipid Res, 48, 1069, 10.1194/jlr.M600471-JLR200
Gregory, 2002, Neutrophil-kupffer cell interaction: a critical component of host defenses to systemic bacterial infections, J Leukoc Biol, 72, 239, 10.1189/jlb.72.2.239
Baffy, 2009, Kupffer cells in non-alcoholic fatty liver disease: the emerging view, J Hepatol, 51, 212, 10.1016/j.jhep.2009.03.008
Dey, 2014, Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages, Front Immunol, 5, 683, 10.3389/fimmu.2014.00683
Jager, 2016, Liver innate immune cells and insulin resistance: the multiple facets of kupffer cells, J Intern Med, 280, 209, 10.1111/joim.12483
Tosello-Trampont, 2012, Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production, J Biol Chem, 287, 40161, 10.1074/jbc.M112.417014
Gallagher, 2005, Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue, Am J Clin Nutr, 81, 903, 10.1093/ajcn/81.4.903
Bachmann, 2001, Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans, Diabetes, 50, 2579, 10.2337/diabetes.50.11.2579
Sciorati, 2015, Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players, Cell Mol Life Sci, 72, 2135, 10.1007/s00018-015-1857-7
Addison, 2014, Intermuscular fat: a review of the consequences and causes, Int J Endocrinol, 2014, 309570, 10.1155/2014/309570
Kim, 2017, Intermuscular adipose tissue content and intramyocellular lipid fatty acid saturation are associated with glucose homeostasis in middle-aged and older adults, Endocrinol Metab, 32, 257, 10.3803/EnM.2017.32.2.257
Goodpaster, 2000, Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus, Am J Clin Nutr, 71, 885, 10.1093/ajcn/71.4.885
Oakes, 1997, Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding, Diabetes, 46, 1768, 10.2337/diabetes.46.11.1768
Goodpaster, 1998, Role of muscle in triglyceride metabolism, Curr Opin Lipidol, 9, 231, 10.1097/00041433-199806000-00008
Granados, 2019, Association of abdominal muscle composition with prediabetes and diabetes: the cardia study, Diabetes Obes Metab, 21, 267, 10.1111/dom.13513
Haykowsky, 2018, Regional adipose distribution and its relationship to exercise intolerance in older obese patients who have heart failure with preserved ejection fraction, JACC Heart Fail, 6, 640, 10.1016/j.jchf.2018.06.002
Terry, 2017, Intermuscular adipose tissue and subclinical coronary artery calcification in midlife: the cardia study (coronary artery risk development in young adults), Arterioscler Thromb Vasc Biol, 37, 2370, 10.1161/ATVBAHA.117.309633
Yim, 2007, Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk, Int J Obes, 31, 1400, 10.1038/sj.ijo.0803621
Ferrara, 2019, Impact of different ectopic fat depots on cardiovascular and metabolic diseases, J Cell Physiol, 234, 21630, 10.1002/jcp.28821
Yafei, 2019, Echocardiographic association of epicardial fat with carotid intima-media thickness in patients with type 2 diabetes, Diab Vasc Dis Res, 16, 378, 10.1177/1479164119827602
Calcaterra, 2018, Epicardial fat thickness in non-obese neurologically impaired children: association with unfavorable cardiometabolic risk profile, Ann Nutr Metab, 72, 96, 10.1159/000484326
Rabkin, 2014, The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis, Metab Syndr Relat Disord, 12, 31, 10.1089/met.2013.0107
Christensen, 2019, Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes, Cardiovasc Diabetol, 18, 114, 10.1186/s12933-019-0917-y
Lopaschuk, 2007, Cardiac energy metabolism in obesity, Circ Res, 101, 335, 10.1161/CIRCRESAHA.107.150417
Iozzo, 2011, Myocardial, perivascular, and epicardial fat, Diabetes Care, 34, S371, 10.2337/dc11-s250
Nosalski, 2017, Perivascular adipose tissue inflammation in vascular disease, Br J Pharmacol, 174, 3496, 10.1111/bph.13705
Fitzgibbons, 2011, Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation, Am J Physiol Heart Circ Physiol, 301, H1425, 10.1152/ajpheart.00376.2011
Xia, 2017, Restoration of perivascular adipose tissue function in diet-induced obese mice without changing bodyweight, Br J Pharmacol, 174, 3443, 10.1111/bph.13703
Costa, 2018, Perivascular adipose tissue as a relevant fat depot for cardiovascular risk in obesity, Front Physiol, 9, 253, 10.3389/fphys.2018.00253
Takaoka, 2009, Periadventitial adipose tissue plays a critical role in vascular remodeling, Circ Res, 105, 906, 10.1161/CIRCRESAHA.109.199653
Gaborit, 2015, Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location, Cardiovasc Res, 108, 62, 10.1093/cvr/cvv208
Nasarre, 2014, Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels, Acta Diabetol, 51, 23, 10.1007/s00592-012-0436-8
Uygun, 2015, The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis, Eur J Intern Med, 26, 37, 10.1016/j.ejim.2014.11.007
Heni, 2010, Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study, Diabetes Metab Res Rev, 26, 200, 10.1002/dmrr.1073
Steven, 2016, Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes, Diabetes Care, 39, 158, 10.2337/dc15-0750
Wong, 2014, Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging, Am J Gastroenterol, 109, 589, 10.1038/ajg.2014.1
Wang, 2014, Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a chinese population, J Am Heart Assoc, 3, e000297, 10.1161/JAHA.113.000297
Pinnick, 2008, Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition, Obesity, 16, 522, 10.1038/oby.2007.110
Navina, 2011, Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity, Sci Transl Med, 3, 107ra110, 10.1126/scitranslmed.3002573
Noel, 2016, Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections, Gut, 65, 100, 10.1136/gutjnl-2014-308043
Yoneshiro, 2011, Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans, Obesity, 9, 1755, 10.1038/oby.2011.125
Wang, 2015, Brown adipose tissue activation is inversely related to central obesity and metabolic parameters in adult human, PLoS ONE, 10, e0123795, 10.1371/journal.pone.0123795
Brendle, 2018, Correlation of brown adipose tissue with other body fat compartments and patient characteristics: a retrospective analysis in a large patient cohort using pet/ct, Acad Radiol, 25, 102, 10.1016/j.acra.2017.09.007
Saito, 2009, High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity, Diabetes, 58, 1526, 10.2337/db09-0530
Matsushita, 2014, Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans, Int J Obes, 38, 812, 10.1038/ijo.2013.206
Hanssen, 2015, Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus, Nat Med, 21, 863, 10.1038/nm.3891
Hanssen, 2015, Short-term cold acclimation recruits brown adipose tissue in obese humans, Diabetes, 65, 1179, 10.2337/db15-1372
Villarroya, 2018, Inflammation of brown/beige adipose tissues in obesity and metabolic disease, J Intern Med, 284, 492, 10.1111/joim.12803
Ferré, 1986, Glucose utilization in vivo and insulin-sensitivity of rat brown adipose tissue in various physiological and pathological conditions, Biochem J, 233, 249, 10.1042/bj2330249
Orava, 2013, Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans, Obesity, 21, 2279, 10.1002/oby.20456
Nedergaard, 2011, New powers of brown fat: fighting the metabolic syndrome, Cell Metab, 13, 238, 10.1016/j.cmet.2011.02.009
Moonen, 2019, Human brown adipose tissue: underestimated target in metabolic disease?, Biochim Biophys Acta Mol Cell Biol Lipids, 1864, 104, 10.1016/j.bbalip.2018.05.012
Ouellet, 2012, Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans, J Clin Invest, 122, 545, 10.1172/JCI60433
Scheele, 2017, Metabolic regulation and the anti-obesity perspectives of human brown fat, Redox Biol, 12, 770, 10.1016/j.redox.2017.04.011
Sakamoto, 2016, Macrophage infiltration into obese adipose tissues suppresses the induction of ucp1 level in mice, Am J Physiol Endocrinol Metab, 310, E676, 10.1152/ajpendo.00028.2015
Roberts-Toler, 2015, Diet-induced obesity causes insulin resistance in mouse brown adipose tissue, Obesity, 23, 1765, 10.1002/oby.21134
Bae, 2014, Activation of pattern recognition receptors in brown adipocytes induces inflammation and suppresses uncoupling protein 1 expression and mitochondrial respiration, Am J Physiol Cell Physiol, 306, C918, 10.1152/ajpcell.00249.2013
Martins, 2017, Thermogenesis, fatty acid synthesis with oxidation, and inflammation in the brown adipose tissue of ob/ob (-/-) mice, Ann Anat, 210, 44, 10.1016/j.aanat.2016.11.013
Chiang, 2009, The protein kinase ikkepsilon regulates energy balance in obese mice, Cell, 138, 961, 10.1016/j.cell.2009.06.046
Kumari, 2016, Irf3 promotes adipose inflammation and insulin resistance and represses browning, J Clin Invest, 126, 2839, 10.1172/JCI86080
Estève, 2015, Human white and brite adipogenesis is supported by msca1 and is impaired by immune cells, Stem Cells, 33, 1277, 10.1002/stem.1916
Kahn, 2006, Mechanisms linking obesity to insulin resistance and type 2 diabetes, Nature, 444, 840, 10.1038/nature05482
Burhans, 2018, Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus, Compr Physiol, 9, 1, 10.1002/cphy.c170040
Raji, 2001, Body fat distribution and insulin resistance in healthy asian indians and caucasians, J Clin Endocrinol Metab, 86, 5366, 10.1210/jcem.86.11.7992
Paradisi, 1999, Dual energy x-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome, Diabetes Care, 22, 1310, 10.2337/diacare.22.8.1310
Mittendorfer, 2009, Relationship between body fat mass and free fatty acid kinetics in men and women, Obesity, 17, 1872, 10.1038/oby.2009.224
Björntorp, 1969, Plasma free fatty acid turnover rate in obesity, Acta Med Scand, 185, 351, 10.1111/j.0954-6820.1969.tb07347.x
Jensen, 1989, Influence of body fat distribution on free fatty acid metabolism in obesity, J Clin Invest, 83, 1168, 10.1172/JCI113997
Reaven, 1988, Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with niddm, Diabetes, 37, 1020, 10.2337/diabetes.37.8.1020
Ferrannini, 1997, Insulin action and non-esterified fatty acids. The European group for the study of insulin resistance (egir), Proc Nutr Soc, 56, 753, 10.1079/PNS19970076
Succurro, 2008, Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals, Obesity, 16, 1881, 10.1038/oby.2008.308
Swarbrick, 2008, Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans, Metab Syndr Relat Disord, 6, 87, 10.1089/met.2007.0029
Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat Med, 7, 941, 10.1038/90984
Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem Biophys Res Commun, 257, 79, 10.1006/bbrc.1999.0255
Hotta, 2000, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler Thromb Vasc Biol, 20, 1595, 10.1161/01.ATV.20.6.1595
Weyer, 2001, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia, J Clin Endocrinol Metab, 86, 1930, 10.1210/jcem.86.5.7463
Bobbert, 2013, Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in caucasians, Diabetes Care, 36, 145, 10.2337/dc12-0703
Markan, 2016, Metabolic fibroblast growth factors (fgfs): mediators of energy homeostasis, Semin Cell Dev Biol, 53, 85, 10.1016/j.semcdb.2015.09.021
Li, 2018, Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat, Nat Commun, 9, 272, 10.1038/s41467-017-02677-9
Hale, 2012, Lack of overt fgf21 resistance in two mouse models of obesity and insulin resistance, Endocrinology, 153, 69, 10.1210/en.2010-1262
Kharitonenkov, 2005, Fgf-21 as a novel metabolic regulator, J Clin Invest, 115, 1627, 10.1172/JCI23606
Markan, 2018, Defining Fgf21 resistance during obesity: controversy, criteria and unresolved questions, F1000Res, 7, 289, 10.12688/f1000research.14117.1
Gustafson, 2015, Insulin resistance and impaired adipogenesis, Trends Endocrinol Metab, 26, 193, 10.1016/j.tem.2015.01.006
Ghaben, 2019, Adipogenesis and metabolic health, Nat Rev Mol Cell Biol, 20, 242, 10.1038/s41580-018-0093-z
Mariman, 2010, Adipocyte extracellular matrix composition, dynamics and role in obesity, Cell Mol Life Sci, 67, 1277, 10.1007/s00018-010-0263-4
Huber, 2007, Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids, Int J Obes, 31, 1004, 10.1038/sj.ijo.0803511
Khan, 2009, Metabolic dysregulation and adipose tissue fibrosis: role of collagen vi, Mol Cell Biol, 29, 1575, 10.1128/MCB.01300-08
Spencer, 2011, Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance, J Clin Endocrinol Metab, 96, E1990, 10.1210/jc.2011-1567
Roedig, 2019, Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy, FEBS J, 286, 2965, 10.1111/febs.14791
Wight, 2014, Versican and the control of inflammation, Matrix Biol, 35, 152, 10.1016/j.matbio.2014.01.015
Sun, 2014, Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction, Nat Commun, 5, 3485, 10.1038/ncomms4485
Leibel, 1989, Physiologic basis for the control of body fat distribution in humans, Annu Rev Nutr, 9, 417, 10.1146/annurev.nu.09.070189.002221
Bonora, 2000, Relationship between regional fat distribution and insulin resistance, Int J Obes Relat Metab Disord, 24, S32, 10.1038/sj.ijo.0801274
Araneta, 2005, Ethnic differences in visceral adipose tissue and type 2 diabetes: filipino, African-American, and white women, Obes Res, 13, 1458, 10.1038/oby.2005.176
Kotronen, 2011, Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome, Obesity, 19, 23, 10.1038/oby.2010.137
Blüher, 2012, Are there still healthy obese patients?, Curr Opin Endocrinol Diabetes Obes, 19, 341, 10.1097/MED.0b013e328357f0a3
Thomas, 2012, The missing risk: mri and mrs phenotyping of abdominal adiposity and ectopic fat, Obesity, 20, 76, 10.1038/oby.2011.142
Zhang, 2015, Associations of different adipose tissue depots with insulin resistance: a systematic review and meta-analysis of observational studies, Sci Rep, 5, 18495, 10.1038/srep18495
Manolopoulos, 2010, Gluteofemoral body fat as a determinant of metabolic health, Int J Obes, 34, 949, 10.1038/ijo.2009.286
Tchkonia, 2013, Mechanisms and metabolic implications of regional differences among fat depots, Cell Metab, 17, 644, 10.1016/j.cmet.2013.03.008
McLaughlin, 2011, Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity, J Clin Endocrinol Metab, 96, E1756, 10.1210/jc.2011-0615
Klein, 2004, Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease, N Engl J Med, 350, 2549, 10.1056/NEJMoa033179
Tran, 2008, Beneficial effects of subcutaneous fat transplantation on metabolism, Cell Metab, 7, 410, 10.1016/j.cmet.2008.04.004
Liu, 2013, Brown adipose tissue transplantation improves whole-body energy metabolism, Cell Res, 23, 851, 10.1038/cr.2013.64
Stanford, 2013, Brown adipose tissue regulates glucose homeostasis and insulin sensitivity, J Clin Invest, 123, 215, 10.1172/JCI62308
Zhu, 2014, Enhanced sympathetic activity in mice with brown adipose tissue transplantation (transbatation), Physiol Behav, 125, 21, 10.1016/j.physbeh.2013.11.008
Ma, 1986, Uptake of glucose and release of fatty acids and glycerol by rat brown adipose tissue in vivo, Can J Physiol Pharmacol, 64, 609, 10.1139/y86-101
Loyd, 2014, Brown fat fuel use and regulation of energy homeostasis, Curr Opin Clin Nutr Metab Care, 17, 368, 10.1097/MCO.0000000000000063
Lee, 2010, A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans, Am J Physiol Endocrinol Metab, 299, E601, 10.1152/ajpendo.00298.2010
Orava, 2011, Different metabolic responses of human brown adipose tissue to activation by cold and insulin, Cell Metab, 14, 272, 10.1016/j.cmet.2011.06.012
Dallner, 2006, Beta3-adrenergic receptors stimulate glucose uptake in brown adipocytes by two mechanisms independently of glucose transporter 4 translocation, Endocrinology, 147, 5730, 10.1210/en.2006-0242
Mössenböck, 2014, Browning of white adipose tissue uncouples glucose uptake from insulin signaling, PLoS ONE, 9, e110428, 10.1371/journal.pone.0110428
Olsen, 2014, Glucose uptake in brown fat cells is dependent on mtor complex 2-promoted glut1 translocation, J Cell Biol, 207, 365, 10.1083/jcb.201403080
Peirce, 2013, Regulation of glucose homoeostasis by brown adipose tissue, Lancet Diabetes Endocrinol, 1, 353, 10.1016/S2213-8587(13)70055-X
Kaisanlahti, 2019, Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes, J Physiol Biochem, 75, 1, 10.1007/s13105-018-0658-5
Chondronikola, 2014, Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans, Diabetes, 63, 4089, 10.2337/db14-0746
Eckel, 1998, American heart association call to action: obesity as a major risk factor for coronary heart disease. Aha nutrition committee, Circulation, 97, 2099, 10.1161/01.CIR.97.21.2099
Stefan, 2018, Metabolically healthy obesity: the low-hanging fruit in obesity treatment?, Lancet Diabetes Endocrinol, 6, 249, 10.1016/S2213-8587(17)30292-9
Wang, 2015, Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis, Heart, 101, 1631, 10.1136/heartjnl-2014-307119
Horwich, 2018, Obesity and the obesity paradox in heart failure, Prog Cardiovasc Dis, 61, 151, 10.1016/j.pcad.2018.05.005
Lavie, 2009, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss, J Am Coll Cardiol, 53, 1925, 10.1016/j.jacc.2008.12.068
St-Pierre, 2002, Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease, Am J Cardiol, 90, 15, 10.1016/S0002-9149(02)02378-0
Grundy, 2004, Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6
Haffner, 2006, Relationship of metabolic risk factors and development of cardiovascular disease and diabetes, Obesity, 14, 121S, 10.1038/oby.2006.291
Alberti, 2009, Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644
Paolisso, 1995, A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of niddm, Diabetologia, 38, 1213, 10.1007/s001250050414
Santomauro, 1999, Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects, Diabetes, 48, 1836, 10.2337/diabetes.48.9.1836
Dutheil, 2018, Cardiovascular risk of adipokines: a review, J Int Med Res, 46, 2082, 10.1177/0300060517706578
Matsuzawa, 2006, The metabolic syndrome and adipocytokines, FEBS Lett, 580, 2917, 10.1016/j.febslet.2006.04.028
Hopkins, 2007, Adiponectin actions in the cardiovascular system, Cardiovasc Res, 74, 11, 10.1016/j.cardiores.2006.10.009
Qiao, 2008, Adiponectin reduces plasma triglyceride by increasing vldl triglyceride catabolism, Diabetes, 57, 1824, 10.2337/db07-0435
Aldhahi, 2003, Adipokines, inflammation, and the endothelium in diabetes, Curr Diab Rep, 3, 293, 10.1007/s11892-003-0020-2
Chen, 2003, Adiponectin stimulates production of nitric oxide in vascular endothelial cells, J Biol Chem, 278, 45021, 10.1074/jbc.M307878200
Du, 2016, Adiponectin at physiologically relevant concentrations enhances the vasorelaxative effect of acetylcholine via cav-1/adipor-1 signaling, PLoS ONE, 11, e0152247, 10.1371/journal.pone.0152247
Sahu, 2003, Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance, Front Neuroendocrinol, 24, 225, 10.1016/j.yfrne.2003.10.001
Söderberg, 1999, Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort, Stroke, 30, 328, 10.1161/01.STR.30.2.328
Söderberg, 1999, Leptin is associated with increased risk of myocardial infarction, J Intern Med, 246, 409, 10.1046/j.1365-2796.1999.00571.x
Wallace, 2001, Plasma leptin and the risk of cardiovascular disease in the west of scotland coronary prevention study (woscops), Circulation, 104, 3052, 10.1161/hc5001.101061
Schulze, 2003, Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure, Eur J Heart Fail, 5, 33, 10.1016/S1388-9842(02)00177-0
Paolisso, 1999, Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men, Hypertension, 34, 1047, 10.1161/01.HYP.34.5.1047
Lehrke, 2004, An inflammatory cascade leading to hyperresistinemia in humans, PLoS Med, 1, e45, 10.1371/journal.pmed.0010045
Verma, 2003, Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction, Circulation, 108, 736, 10.1161/01.CIR.0000084503.91330.49
Calabro, 2004, Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways, Circulation, 110, 3335, 10.1161/01.CIR.0000147825.97879.E7
Reilly, 2005, Resistin is an inflammatory marker of atherosclerosis in humans, Circulation, 111, 932, 10.1161/01.CIR.0000155620.10387.43
Ouchi, 1999, Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin, Circulation, 100, 2473, 10.1161/01.CIR.100.25.2473
Fatkhullina, 2016, The role of cytokines in the development of atherosclerosis, Biochemistry (Mosc), 81, 1358, 10.1134/S0006297916110134
Burstein, 1996, Cytokine-induced alteration of platelet and hemostatic function, Stem Cells, 14, 154, 10.1002/stem.5530140720
Bhagat, 1997, Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo, Circulation, 96, 3042, 10.1161/01.CIR.96.9.3042
Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 836, 10.1056/NEJM200003233421202
Ong, 2015, The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the fenofibrate intervention and event lowering in diabetes study, Diabetologia, 58, 464, 10.1007/s00125-014-3458-7
Ong, 2018, Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: the multi-ethnic study of atherosclerosis, Atherosclerosis, 281, 10.1016/j.atherosclerosis.2018.10.011
Domouzoglou, 2015, Fibroblast growth factors in cardiovascular disease: the emerging role of fgf21, Am J Physiol Heart Circ Physiol, 309, H1029, 10.1152/ajpheart.00527.2015
Lin, 2010, Serum levels of fgf-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile, PLoS ONE, 5, e15534, 10.1371/journal.pone.0015534
Shen, 2013, Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease, Cardiovasc Diabetol, 12, 124, 10.1186/1475-2840-12-124
Ebert, 2018, Relationship between 12 adipocytokines and distinct components of the metabolic syndrome, J Clin Endocrinol Metab, 103, 1015, 10.1210/jc.2017-02085
Lee, 2014, Serum fgf21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status, Clin Endocrinol, 80, 57, 10.1111/cen.12134
Kharitonenkov, 2007, The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21, Endocrinology, 148, 774, 10.1210/en.2006-1168
Gaich, 2013, The effects of ly2405319, an fgf21 analog, in obese human subjects with type 2 diabetes, Cell Metab, 18, 333, 10.1016/j.cmet.2013.08.005
Berg, 2005, Adipose tissue, inflammation, and cardiovascular disease, Circ Res, 96, 939, 10.1161/01.RES.0000163635.62927.34
Forouzandeh, 2013, Does quantifying epicardial and intrathoracic fat with noncontrast computed tomography improve risk stratification beyond calcium scoring alone?, Circ Cardiovasc Imaging, 6, 58, 10.1161/CIRCIMAGING.112.976316
Iacobellis, 2005, Epicardial adipose tissue and insulin resistance in obese subjects, J Clin Endocrinol Metab, 90, 6300, 10.1210/jc.2005-1087
Iacobellis, 2008, Do cardiac and perivascular adipose tissue play a role in atherosclerosis?, Curr Diab Rep, 8, 20, 10.1007/s11892-008-0005-2
Verhagen, 2012, Coronary perivascular adipose tissue characteristics are related to atherosclerotic plaque size and composition. A post-mortem study, Atherosclerosis, 225, 99, 10.1016/j.atherosclerosis.2012.08.031
Fox, 2010, Periaortic fat deposition is associated with peripheral arterial disease: the framingham heart study, Circ Cardiovasc Imaging, 3, 515, 10.1161/CIRCIMAGING.110.958884
Iacobellis, 2003, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk, J Clin Endocrinol Metab, 88, 5163, 10.1210/jc.2003-030698
Mookadam, 2010, Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study, Heart Views, 11, 103, 10.4103/1995-705X.76801
Nelson, 2011, Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?, J Am Soc Echocardiogr, 24, 339, 10.1016/j.echo.2010.11.008
Gorter, 2008, Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography, Am J Cardiol, 102, 380, 10.1016/j.amjcard.2008.04.002
Mahabadi, 2010, Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis, Atherosclerosis, 211, 195, 10.1016/j.atherosclerosis.2010.02.013
Lim, 2014, Links between ectopic fat and vascular disease in humans, Arterioscler Thromb Vasc Biol, 34, 1820, 10.1161/ATVBAHA.114.303035
Verhagen, 2011, Perivascular adipose tissue as a cause of atherosclerosis, Atherosclerosis, 214, 3, 10.1016/j.atherosclerosis.2010.05.034
Yudkin, 2005, Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease, Lancet, 365, 1817, 10.1016/S0140-6736(05)66585-3
Sun, 2013, Effect of high free fatty acids on the anti-contractile response of perivascular adipose tissue in rat aorta, J Mol Cell Cardiol, 63, 169, 10.1016/j.yjmcc.2013.07.018
Sacks, 2011, Human epicardial fat: what is new and what is missing?, Clin Exp Pharmacol Physiol, 38, 879, 10.1111/j.1440-1681.2011.05601.x
Kralova Lesna, 2015, Is the amount of coronary perivascular fat related to atherosclerosis?, Physiol Res, 64, S435, 10.33549/physiolres.933151
Ketonen, 2010, Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese c57bl/6 mice, Circ J, 74, 1479, 10.1253/circj.CJ-09-0661
Spiroglou, 2010, Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis, J Atheroscler Thromb, 17, 115, 10.5551/jat.1735
Arangalage, 2019, Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis, Arch Cardiovasc Dis, 112, 594, 10.1016/j.acvd.2019.06.005
Fernández-Alfonso, 2013, Mechanisms of perivascular adipose tissue dysfunction in obesity, Int J Endocrinol, 2013, 402053, 10.1155/2013/402053
Berbée, 2015, Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development, Nat Commun, 6, 6356, 10.1038/ncomms7356
Hung, 2014, Rictor/mtorc2 loss in the myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease, Cell Rep, 8, 256, 10.1016/j.celrep.2014.06.007
Bray, 2018, The science of obesity management: an endocrine society scientific statement, Endocr Rev, 39, 79, 10.1210/er.2017-00253
Clifton, 2018, Effects of different weight loss approaches on cvd risk, Curr Atheroscler Rep, 20, 27, 10.1007/s11883-018-0728-8
Harrington, 2009, A review and meta-analysis of the effect of weight loss on all-cause mortality risk, Nutr Res Rev, 22, 93, 10.1017/S0954422409990035
Ross, 1997, Effects of diet- and exercise-induced weight loss on visceral adipose tissue in men and women, Sports Med, 24, 55, 10.2165/00007256-199724010-00005
van Gemert, 2019, Effect of diet with or without exercise on abdominal fat in postmenopausal women - a randomised trial, BMC Public Health, 19, 174, 10.1186/s12889-019-6510-1
Borges, 2019, Exercise training and/or diet on reduction of intra-abdominal adipose tissue and risk factors for cardiovascular disease, Eur J Clin Nutr, 73, 1063, 10.1038/s41430-018-0318-4
Ross, 2000, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial, Ann Intern Med, 133, 92, 10.7326/0003-4819-133-2-200007180-00008
Janssen, 1999, Effects of sex on the change in visceral, subcutaneous adipose tissue and skeletal muscle in response to weight loss, Int J Obes Relat Metab Disord, 23, 1035, 10.1038/sj.ijo.0801038
Ryan, 2014, Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women, J Am Geriatr Soc, 62, 607, 10.1111/jgs.12749
Janssen, 2002, Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women, Diabetes Care, 25, 431, 10.2337/diacare.25.3.431
Gregg, 2016, Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the look ahead randomised clinical trial, Lancet Diabetes Endocrinol, 4, 913, 10.1016/S2213-8587(16)30162-0
Baum, 2017, Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the look ahead trial, Lancet Diabetes Endocrinol, 5, 808, 10.1016/S2213-8587(17)30176-6
Wing, 2010, Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look ahead trial, Arch Intern Med, 170, 1566, 10.1001/archinternmed.2010.334
Després, 1985, Lack of relationship between changes in adiposity and plasma lipids following endurance training, Atherosclerosis, 54, 135, 10.1016/0021-9150(85)90173-X
Simonsen, 2004, The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects, Diabetologia, 47, 652, 10.1007/s00125-004-1374-y
Klein, 1994, Fat metabolism during low-intensity exercise in endurance-trained and untrained men, Am J Physiol, 267, E934, 10.1152/ajpendo.1994.267.6.E934
Gollisch, 2009, Effects of exercise training on subcutaneous and visceral adipose tissue in normal- and high-fat diet-fed rats, Am J Physiol Endocrinol Metab, 297, E495, 10.1152/ajpendo.90424.2008
Poirier, 2001, Exercise in weight management of obesity, Cardiol Clin, 19, 459, 10.1016/S0733-8651(05)70229-0
O'Donovan, 2009, Fat distribution in men of different waist girth, fitness level and exercise habit, Int J Obes, 33, 1356, 10.1038/ijo.2009.189
Lee, 2005, Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes, J Appl Physiol., 99, 1220, 10.1152/japplphysiol.00053.2005
Stewart, 2005, Exercise and risk factors associated with metabolic syndrome in older adults, Am J Prev Med, 28, 9, 10.1016/j.amepre.2004.09.006
Lee, 2019, Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight, Diabetologia, 62, 1048, 10.1007/s00125-019-4866-5
Lehnig, 2019, Exercise training induces depot-specific adaptations to white and brown adipose tissue, Science, 11, 425, 10.1016/j.isci.2018.12.033
Sakurai, 2013, The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue, Int J Endocrinol, 2013, 801743, 10.1155/2013/801743
Zachwieja, 1997, Voluntary wheel running decreases adipose tissue mass and expression of leptin mRNA in osborne-mendel rats, Diabetes, 46, 1159, 10.2337/diabetes.46.7.1159
Berggren, 2005, Fat as an endocrine organ: influence of exercise, J Appl Physiol., 99, 757, 10.1152/japplphysiol.00134.2005
Halle, 1999, Concurrent reductions of serum leptin and lipids during weight loss in obese men with type ii diabetes, Am J Physiol, 277, E277, 10.1152/ajpendo.1999.277.2.E277
Miyatake, 2004, Changes in serum leptin concentrations in overweight japanese men after exercise, Diabetes Obes Metab, 6, 332, 10.1111/j.1462-8902.2004.00351.x
Polak, 2006, Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women, Metabolism, 55, 1375, 10.1016/j.metabol.2006.06.008
Hulver, 2002, Adiponectin is not altered with exercise training despite enhanced insulin action, Am J Physiol Endocrinol Metab, 283, E861, 10.1152/ajpendo.00150.2002
Boudou, 2003, Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men, Eur J Endocrinol, 149, 421, 10.1530/eje.0.1490421
O'Leary, 2006, Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat, J Appl Physiol., 100, 1584, 10.1152/japplphysiol.01336.2005
Kondo, 2006, Effect of exercise on circulating adipokine levels in obese young women, Endocr J, 53, 189, 10.1507/endocrj.53.189
Fatouros, 2005, Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related, J Clin Endocrinol Metab, 90, 5970, 10.1210/jc.2005-0261
Blüher, 2006, Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training, J Clin Endocrinol Metab, 91, 2310, 10.1210/jc.2005-2556
Christiansen, 2010, Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study, Am J Physiol Endocrinol Metab, 298, E824, 10.1152/ajpendo.00574.2009
Bruun, 2006, Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects, Am J Physiol Endocrinol Metab, 290, E961, 10.1152/ajpendo.00506.2005
Miyazaki, 2010, Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin, Life Sci, 86, 691, 10.1016/j.lfs.2010.03.004
García-Hermoso, 2017, Exercise, adipokines and pediatric obesity: a meta-analysis of randomized controlled trials, Int J Obes, 41, 475, 10.1038/ijo.2016.230
Yang, 2011, Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-a levels and arterial stiffness in obese women, Clin Endocrinol, 75, 464, 10.1111/j.1365-2265.2011.04078.x
Yang, 2019, Exercise ameliorates the fgf21-adiponectin axis impairment in diet-induced obese mice, Endocr Connect, 8, 596, 10.1530/EC-19-0034
Stanford, 2015, A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis, Diabetes, 64, 2002, 10.2337/db14-0704
Sutherl, 2009, Exercise and adrenaline increase pgc-1{alpha} mRNA expression in rat adipose tissue, J Physiol, 587, 1607, 10.1113/jphysiol.2008.165464
Trevellin, 2014, Exercise training induces mitochondrial biogenesis and glucose uptake in subcutaneous adipose tissue through enos-dependent mechanisms, Diabetes, 63, 2800, 10.2337/db13-1234
De Matteis, 2013, Exercise as a new physiological stimulus for brown adipose tissue activity, Nutr Metab Cardiovasc Dis, 23, 582, 10.1016/j.numecd.2012.01.013
Stinkens, 2018, Exercise training-induced effects on the abdominal subcutaneous adipose tissue phenotype in humans with obesity, J Appl Physiol., 125, 1585, 10.1152/japplphysiol.00496.2018
Vosselman, 2015, Low brown adipose tissue activity in endurance-trained compared with lean sedentary men, Int J Obes (Lond), 39, 1696, 10.1038/ijo.2015.130
Otero-Díaz, 2018, Exercise induces white adipose tissue browning across the weight spectrum in humans, Front Physiol, 9, 1781, 10.3389/fphys.2018.01781
Dewal, 2019, Effects of exercise on brown and beige adipocytes, Biochim Biophys Acta Mol Cell Biol Lipids, 1864, 71, 10.1016/j.bbalip.2018.04.013
Forsythe, 2008, Obesity and inflammation: the effects of weight loss, Nutr Res Rev, 21, 117, 10.1017/S0954422408138732
Selvin, 2007, The effect of weight loss on c-reactive protein: a systematic review, Arch Intern Med, 167, 31, 10.1001/archinte.167.1.31
Heilbronn, 2001, Energy restriction and weight loss on very-low-fat diets reduce c-reactive protein concentrations in obese, healthy women, Arterioscler Thromb Vasc Biol, 21, 968, 10.1161/01.ATV.21.6.968
Madsen, 2008, Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study, Eur J Endocrinol, 158, 179, 10.1530/EJE-07-0721
Ellsworth, 2015, Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification, Obesity, 23, 1312, 10.1002/oby.21079
You, 2013, Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms, Sports Med, 43, 243, 10.1007/s40279-013-0023-3
Giugliano, 2004, Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women, Br J Plast Surg, 57, 190, 10.1016/j.bjps.2003.12.010
Gabriely, 2002, Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?, Diabetes, 51, 2951, 10.2337/diabetes.51.10.2951
Illán-Gómez, 2012, Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery, Obes Surg, 22, 950, 10.1007/s11695-012-0643-y
Moschen, 2010, Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression, Gut, 59, 1259, 10.1136/gut.2010.214577
Cancello, 2005, Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss, Diabetes, 54, 2277, 10.2337/diabetes.54.8.2277
Trachta, 2014, Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients, Mol Cell Endocrinol, 383, 96, 10.1016/j.mce.2013.11.013
Hagman, 2017, The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans, Metabolism, 70, 12, 10.1016/j.metabol.2017.01.030
Kratz, 2016, Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation, Obesity, 24, 1438, 10.1002/oby.21524
Šrámková, 2016, Comparison of early (2 days) and later (28 days) response of adipose tissue to very low-calorie diet in obese women, J Clin Endocrinol Metab, 101, 5021, 10.1210/jc.2016-2161
Magkos, 2016, Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity, Cell Metab, 23, 591, 10.1016/j.cmet.2016.02.005
Wernstedt Asterholm, 2014, Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling, Cell Metab, 20, 103, 10.1016/j.cmet.2014.05.005
Maruthur, 2016, Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis, Ann Intern Med, 164, 740, 10.7326/M15-2650
Rena, 2013, Molecular mechanism of action of metformin: old or new insights?, Diabetologia, 56, 1898, 10.1007/s00125-013-2991-0
Rena, 2017, The mechanisms of action of metformin, Diabetologia, 60, 1577, 10.1007/s00125-017-4342-z
Yerevanian, 2019, Metformin: mechanisms in human obesity and weight loss, Curr Obes Rep, 8, 156, 10.1007/s13679-019-00335-3
Stumvoll, 1995, Metabolic effects of metformin in non-insulin-dependent diabetes mellitus, N Engl J Med, 333, 550, 10.1056/NEJM199508313330903
Aghili, 2014, Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin, J Diabetes Metab Disord, 13, 88, 10.1186/s40200-014-0088-z
Feng, 2019, Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial, J Diabetes Investig, 10, 399, 10.1111/jdi.12888
Kim, 2013, Central administration of metformin into the third ventricle of c57bl/6 mice decreases meal size and number and activates hypothalamic s6 kinase, Am J Physiol Regul Integr Comp Physiol, 305, R499, 10.1152/ajpregu.00099.2013
Helvaci, 2008, Metformin and parameters of physical health, Intern Med, 47, 697, 10.2169/internalmedicine.47.0787
Lee, 1996, Metformin in noninsulin-dependent diabetes mellitus, Pharmacotherapy, 16, 327, 10.1002/j.1875-9114.1996.tb02964.x
Tokubuchi, 2017, Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats, PLoS ONE, 12, e0171293, 10.1371/journal.pone.0171293
Geerling, 2014, Metformin lowers plasma triglycerides by promoting vldl-triglyceride clearance by brown adipose tissue in mice, Diabetes, 63, 880, 10.2337/db13-0194
Watanabe, 2017, Adipose tissue-derived omentin-1 function and regulation, Compr Physiol, 7, 765, 10.1002/cphy.c160043
Lin, 2017, Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein a5 as part of the ampk/lxrα signaling pathway, Oncotarget, 8, 108802, 10.18632/oncotarget.22163
Zhu, 2018, Metformin attenuates triglyceride accumulation in hepg2 cells through decreasing stearyl-coenzyme a desaturase 1 expression, Lipids Health Dis, 17, 114, 10.1186/s12944-018-0762-0
Fung, 2015, Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients, Cardiovasc Diabetol, 14, 137, 10.1186/s12933-015-0304-2
Griffin, 2017, Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes, Diabetologia, 60, 1620, 10.1007/s00125-017-4337-9
Salpeter, 2008, Meta-analysis: metformin treatment in persons at risk for diabetes mellitus, Am J Med, 121, 149, 10.1016/j.amjmed.2007.09.016
Adeshirlarijaney, 2019, Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota, Am J Physiol Endocrinol Metab, 317, E1121, 10.1152/ajpendo.00245.2019
Saisho, 2015, Metformin and inflammation: its potential beyond glucose-lowering effect, Endocr Metab Immune Disord Drug Targets, 15, 196, 10.2174/1871530315666150316124019
Li, 2009, Metformin inhibits nuclear factor kappab activation and decreases serum high-sensitivity c-reactive protein level in experimental atherogenesis of rabbits, Heart Vessels, 24, 446, 10.1007/s00380-008-1137-7
Ruggiero-Lopez, 1999, Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation, Biochem Pharmacol, 58, 1765, 10.1016/S0006-2952(99)00263-4
Beisswenger, 2003, Metformin inhibition of glycation processes, Diabetes Metab, 29, 6S95, 10.1016/S1262-3636(03)72793-1
Burmeister, 2017, The hypothalamic glucagon-like peptide 1 receptor is sufficient but not necessary for the regulation of energy balance and glucose homeostasis in mice, Diabetes, 66, 372, 10.2337/db16-1102
López-Ferreras, 2018, Lateral hypothalamic glp-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight, Mol Psychiatry, 23, 1157, 10.1038/mp.2017.187
Garber, 2011, Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes, Diabetes Obes Metab, 13, 348, 10.1111/j.1463-1326.2010.01356.x
Nauck, 2013, Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the lead-2 study, Diabetes Obes Metab, 15, 204, 10.1111/dom.12012
Nauck, 2009, Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the lead (liraglutide effect and action in diabetes)-2 study, Diabetes Care, 32, 84, 10.2337/dc08-1355
Jendle, 2009, Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue, Diabetes Obes Metab, 11, 1163, 10.1111/j.1463-1326.2009.01158.x
Inoue, 2011, Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese japanese patients with type 2 diabetes, Cardiovasc Diabetol, 10, 109, 10.1186/1475-2840-10-109
Hansotia, 2007, Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure, J Clin Invest, 117, 143, 10.1172/JCI25483
Kim Chung, 2009, Exendin-4, a glp-1 receptor agonist, directly induces adiponectin expression through protein kinase a pathway and prevents inflammatory adipokine expression, Biochem Biophys Res Commun, 390, 613, 10.1016/j.bbrc.2009.10.015
Ejarque, 2019, Role of adipose tissue glp-1r expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes, Sci Rep, 9, 6274, 10.1038/s41598-019-42770-1
Marso, 2016, Liraglutide and cardiovascular outcomes in type 2 diabetes, N Engl J Med, 375, 311, 10.1056/NEJMoa1603827
Ansar, 2011, Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins, Cardiovasc Diabetol, 10, 61, 10.1186/1475-2840-10-61
Arakawa, 2010, Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4, Diabetes, 59, 1030, 10.2337/db09-1694
Gaspari, 2011, A glp-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an apoe-/- mouse model, Diab Vasc Dis Res, 8, 117, 10.1177/1479164111404257
Iacobellis, 2017, Liraglutide causes large and rapid epicardial fat reduction, Obesity, 25, 311, 10.1002/oby.21718
Gallo, 2015, Probing sglt2 as a therapeutic target for diabetes: basic physiology and consequences, Diab Vasc Dis Res, 12, 78, 10.1177/1479164114561992
Neal, 2017, Canagliflozin and cardiovascular and renal events in type 2 diabetes, N Engl J Med, 377, 644, 10.1056/NEJMoa1611925
Chilton, 2015, Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes, Diabetes Obes Metab, 17, 1180, 10.1111/dom.12572
Tikkanen, 2015, Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension, Diabetes Care, 38, 420, 10.2337/dc14-1096
Tahara, 2013, Effects of sglt2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice, Eur J Pharmacol, 715, 246, 10.1016/j.ejphar.2013.05.014
Honda, 2016, The selective sglt2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice, PLoS ONE, 11, e0146337, 10.1371/journal.pone.0146337
Qiang, 2015, Treatment with the sglt2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus, Diabetol Metab Syndr, 7, 104, 10.1186/s13098-015-0102-8
Osataphan, 2019, Sglt2 inhibition reprograms systemic metabolism via fgf21-dependent and -independent mechanisms, JCI Insight, 4, 1, 10.1172/jci.insight.123130
Kuchay, 2018, Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (e-lift trial), Diabetes Care, 41, 1801, 10.2337/dc18-0165
Häring, 2013, Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial, Diabetes Care, 36, 3396, 10.2337/dc12-2673
Kovacs, 2014, Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: A 24-week, randomized, placebo-controlled trial, Diabetes Obes Metab, 16, 147, 10.1111/dom.12188
Rosenstock, 2014, Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes, Diabetes Care, 37, 1815, 10.2337/dc13-3055
Xu, 2017, Sglt2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing m2 macrophages in diet-induced obese mice, EBiomedicine, 20, 137, 10.1016/j.ebiom.2017.05.028
Obata, 2016, Tofogliflozin improves insulin resistance in skeletal muscle and accelerates lipolysis in adipose tissue in male mice, Endocrinology, 157, 1029, 10.1210/en.2015-1588
Galanakis, 2015, Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery, World J Surg, 39, 417, 10.1007/s00268-014-2826-2
Keidar, 2014, Baseline abdominal lipid partitioning is associated with the metabolic response to bariatric surgery, Obes Surg, 24, 1709, 10.1007/s11695-014-1249-3
Faria, 2014, Metabolic score: insights on the development and prediction of remission of metabolic syndrome after gastric bypass, Ann Surg, 260, 279, 10.1097/SLA.0000000000000686
Toro-Ramos, 2015, Continued loss in visceral and intermuscular adipose tissue in weight-stable women following bariatric surgery, Obesity, 23, 62, 10.1002/oby.20932
Yoon, 2007, Changes in the abdominal fat distribution after gastrectomy: computed tomography assessment, ANZ J Surg, 77, 121, 10.1111/j.1445-2197.2006.03990.x
Kim, 2014, Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: a prospective 2-year follow up, J Diabetes Investig, 5, 221, 10.1111/jdi.12137
Singh, 2017, Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression, Metabolism, 69, 1, 10.1016/j.metabol.2016.12.012
Gaborit, 2015, Ectopic fat storage in the pancreas using 1h-mrs: importance of diabetic status and modulation with bariatric surgery-induced weight loss, Int J Obes, 39, 480, 10.1038/ijo.2014.126
Cancello, 2013, Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects, Int J Obes, 37, 867, 10.1038/ijo.2013.7
Andersson, 2014, Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss, Diabetes Care, 37, 1831, 10.2337/dc13-2395
Chen, 2012, Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery, Surg Endosc, 26, 1476, 10.1007/s00464-011-2059-5
Auguet, 2014, Clinical and adipocytokine changes after bariatric surgery in morbidly obese women, Obesity, 22, 188, 10.1002/oby.20470
Sams, 2016, Effect of bariatric surgery on systemic and adipose tissue inflammation, Surg Endosc, 30, 3499, 10.1007/s00464-015-4638-3
Miller, 2011, Serial changes in inflammatory biomarkers after roux-en-y gastric bypass surgery, Surg Obes Relat Dis, 7, 618, 10.1016/j.soard.2011.03.006
Aghamohammadzadeh, 2013, Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity, J Am Coll Cardiol, 62, 128, 10.1016/S0140-6736(13)60458-4
Emery, 2007, Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation, Obes Surg, 17, 759, 10.1007/s11695-007-9140-0
Gumbau, 2014, A prospective study on inflammatory parameters in obese patients after sleeve gastrectomy, Obes Surg, 24, 903, 10.1007/s11695-014-1186-1
Holdstock, 2005, Crp reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects, Int J Obes, 29, 1275, 10.1038/sj.ijo.0803000
Iannelli, 2009, Impact of laparoscopic roux-en-y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women, Obes Surg, 19, 577, 10.1007/s11695-008-9764-8
Iannelli, 2014, Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic roux-en-y gastric bypass, Surg Endosc, 28, 500, 10.1007/s00464-013-3191-1
Monte, 2012, Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after roux-en-y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus, Surgery, 151, 587, 10.1016/j.surg.2011.09.038
Viardot, 2010, The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes, J Clin Endocrinol Metab, 95, 2845, 10.1210/jc.2009-2371
Aron-Wisnewsky, 2009, Human adipose tissue macrophages: M1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss, J Clin Endocrinol Metab, 94, 4619, 10.1210/jc.2009-0925
Pardina, 2012, Only c-reactive protein, but not tnf-α or il6, reflects the improvement in inflammation after bariatric surgery, Obes Surg, 22, 131, 10.1007/s11695-011-0546-3
Lips, 2014, Calorie restriction and roux-en-y gastric bypass have opposing effects on circulating fgf21 in morbidly obese subjects, Clin Endocrinol, 81, 862, 10.1111/cen.12496
Jansen, 2011, Alterations of hormonally active fibroblast growth factors after roux-en-y gastric bypass surgery, Dig Dis, 29, 48, 10.1159/000324128
Pei, 2018, Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease, Lipids Health Dis, 17, 243, 10.1186/s12944-018-0875-5
Gómez-Ambrosi, 2017, Fgf19 and fgf21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss, Clin Nutr, 36, 861, 10.1016/j.clnu.2016.04.027
Haluzíková, 2013, Laparoscopic sleeve gastrectomy differentially affects serum concentrations of fgf-19 and fgf-21 in morbidly obese subjects, Obesity, 21, 1335, 10.1002/oby.20208
Angelin, 2012, Circulating fibroblast growth factors as metabolic regulators–a critical appraisal, Cell Metab, 16, 693, 10.1016/j.cmet.2012.11.001
Sheng, 2017, The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis, Obes Surg, 27, 2724, 10.1007/s11695-017-2866-4
Sjöström, 2014, Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications, JAMA, 311, 2297, 10.1001/jama.2014.5988
Sjöström, 2013, Review of the key results from the Swedish obese subjects (sos) trial - a prospective controlled intervention study of bariatric surgery, J Intern Med, 273, 219, 10.1111/joim.12012
Sjöström, 2004, Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery, N Engl J Med, 351, 2683, 10.1056/NEJMoa035622
Diamant, 2003, Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence, Drugs, 63, 1373, 10.2165/00003495-200363130-00004
Day, 1999, Thiazolidinediones: a new class of antidiabetic drugs, Diabet Med, 16, 179, 10.1046/j.1464-5491.1999.00023.x
Mauvais-Jarvis, 2001, Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights, Diabetes Metab, 27, 415
Fonseca, 2003, Effect of thiazolidinediones on body weight in patients with diabetes mellitus, Am J Med, 115, 42S, 10.1016/j.amjmed.2003.09.005
Adams, 1997, Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation, J Clin Invest, 100, 3149, 10.1172/JCI119870
Nichols, 2007, Weight changes following the initiation of new anti-hyperglycaemic therapies, Diabetes Obes Metab, 9, 96, 10.1111/j.1463-1326.2006.00580.x
Boden, 2006, Recent findings concerning thiazolidinediones in the treatment of diabetes, Expert Opin Investig Drugs, 15, 243, 10.1517/13543784.15.3.243
Maeda, 2001, PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein, Diabetes, 50, 2094, 10.2337/diabetes.50.9.2094
Pellegrinelli, 2016, Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues, Diabetologia, 59, 1075, 10.1007/s00125-016-3933-4
Miyazaki, 2002, Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients, J Clin Endocrinol Metab, 87, 2784, 10.1210/jcem.87.6.8567
Dietze-Schroeder, 2005, Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors, Diabetes, 54, 2003, 10.2337/diabetes.54.7.2003
Zoico, 2009, The effects of adiponectin on interleukin-6 and mcp-1 secretion in lipopolysaccharide-treated 3t3-l1 adipocytes: role of the nf-kappab pathway, Int J Mol Med, 24, 847, 10.3892/ijmm_00000302
Fasshauer, 2003, Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3t3-l1 adipocytes, Biochem Biophys Res Commun, 301, 1045, 10.1016/S0006-291X(03)00090-1
Kappes, 2000, Influences of ionomycin, dibutyryl-cycloamp and tumour necrosis factor-alpha on intracellular amount and secretion of apm1 in differentiating primary human preadipocytes, Horm Metab Res, 32, 548, 10.1055/s-2007-978684
Goldberg, 2005, A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia, Diabetes Care, 28, 1547, 10.2337/diacare.28.7.1547
Erdmann, 2009, Thiazolidinediones and cardiovascular risk - a question of balance, Curr Cardiol Rev, 5, 155, 10.2174/157340309788970333
van Wijk, 2003, Thiazolidinediones and blood lipids in type 2 diabetes, Arterioscler Thromb Vasc Biol, 23, 1744, 10.1161/01.ATV.0000090521.25968.4D
Dormandy, 2005, Secondary prevention of macrovascular events in patients with type 2 diabetes in the proactive study (prospective pioglitazone clinical trial in macrovascular events): a randomised controlled trial, Lancet, 366, 1279, 10.1016/S0140-6736(05)67528-9
Ridker, 2017, Antiinflammatory therapy with canakinumab for atherosclerotic disease, N Engl J Med, 377, 1119, 10.1056/NEJMoa1707914
Tardif, 2019, Efficacy and safety of low-dose colchicine after myocardial infarction, N Engl J Med, 381, 2497, 10.1056/NEJMoa1912388
Blanco-Colio, 2003, Anti-inflammatory and immunomodulatory effects of statins, Kidney Int, 63, 12, 10.1046/j.1523-1755.2003.00744.x
Jialal, 2001, Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive c-reactive protein levels, Circulation, 103, 1933, 10.1161/01.CIR.103.15.1933
Shovman, 2002, Antiinflammatory and immunomodulatory properties of statins, Immunol Res, 25, 271, 10.1385/IR:25:3:271
Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1
Baigent, 2010, Efficacy and safety of more intensive lowering of ldl cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5
Soucek, 2015, Effects of atorvastatin (80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation, Am J Cardiol, 116, 1443, 10.1016/j.amjcard.2015.07.067
Takei, 2019, Myeloid hmg-coa (3-hydroxy-3-methylglutaryl-coenzyme a) reductase determines adipose tissue inflammation, insulin resistance and hepatic steatosis in diet-induced obese mice, Diabetes, 69, 158, 10.2337/db19-0076
Turnbaugh, 2008, Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome, Cell Host Microbe, 3, 213, 10.1016/j.chom.2008.02.015
Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a
Drissi, 2016, Metabolic role of lactobacilli in weight modification in humans and animals, Microb Pathog, 106, 182, 10.1016/j.micpath.2016.03.006
Patil, 2012, Molecular analysis of gut microbiota in obesity among indian individuals, J Biosci, 37, 647, 10.1007/s12038-012-9244-0
Liu, 2017, Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention, Nat Med, 23, 859, 10.1038/nm.4358
Bik, 2015, You lose some, you win some: weight loss induces microbiota and metabolite shifts, EBioMedicine, 2, 806, 10.1016/j.ebiom.2015.07.037
Damms-Machado, 2015, Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption, Biomed Res Int, 2015, 806248, 10.1155/2015/806248
Bäckhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci USA, 101, 15718, 10.1073/pnas.0407076101
Bäckhed, 2007, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc Natl Acad Sci USA, 104, 979, 10.1073/pnas.0605374104
Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414
Cani, 2012, Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity, Gut Microbes, 3, 279, 10.4161/gmic.19625
Lau, 2017, Bridging the gap between gut microbial dysbiosis and cardiovascular diseases, Nutrients, 9, 1, 10.3390/nu9080859
Cani, 2008, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, 57, 1470, 10.2337/db07-1403
Moreira, 2012, Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia, Br J Nutr, 108, 801, 10.1017/S0007114512001213
de La Serre, 2010, Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation, Am J Physiol Gastrointest Liver Physiol, 299, G440, 10.1152/ajpgi.00098.2010
Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491
Lassenius, 2011, Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation, Diabetes Care, 34, 1809, 10.2337/dc10-2197
Brun, 2007, Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis, Am J Physiol Gastrointest Liver Physiol, 292, G518, 10.1152/ajpgi.00024.2006
Jiao, 2018, Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in nafld, Gut, 67, 1881, 10.1136/gutjnl-2017-314307
Pierre, 2016, Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice, Am J Physiol Gastrointest Liver Physiol, 311, G286, 10.1152/ajpgi.00202.2016
Koren, 2011, Human oral, gut, and plaque microbiota in patients with atherosclerosis, Proc Natl Acad Sci USA, 108, 4592, 10.1073/pnas.1011383107
Ridlon, 2014, Bile acids and the gut microbiome, Curr Opin Gastroenterol, 30, 332, 10.1097/MOG.0000000000000057
Schaap, 2014, Bile acid receptors as targets for drug development, Nat Rev Gastroenterol Hepatol, 11, 55, 10.1038/nrgastro.2013.151
Cornejo-Pareja, 2019, Importance of gut microbiota in obesity, Eur J Clin Nutr, 72, 26, 10.1038/s41430-018-0306-8
Russell, 2003, The enzymes, regulation, and genetics of bile acid synthesis, Annu Rev Biochem, 72, 137, 10.1146/annurev.biochem.72.121801.161712
Cariou, 2011, Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults, Nutr Metab, 8, 48, 10.1186/1743-7075-8-48
Svensson, 2013, The tgr5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate, Biochem Biophys Res Commun, 433, 563, 10.1016/j.bbrc.2013.03.031
Watanabe, 2006, Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation, Nature, 439, 484, 10.1038/nature04330
Cariou, 2006, The farnesoid x receptor modulates adiposity and peripheral insulin sensitivity in mice, J Biol Chem, 281, 11039, 10.1074/jbc.M510258200
Frikke-Schmidt, 2016, Does bariatric surgery improve adipose tissue function?, Obes Rev, 17, 795, 10.1111/obr.12429
Keitel, 2008, Expression and function of the bile acid receptor tgr5 in kupffer cells, Biochem Biophys Res Commun, 372, 78, 10.1016/j.bbrc.2008.04.171
Lou, 2014, Gpbar1/tgr5 mediates bile acid-induced cytokine expression in murine kupffer cells, PLoS ONE, 9, e93567, 10.1371/journal.pone.0093567
Wang, 2008, Farnesoid x receptor antagonizes nuclear factor kappab in hepatic inflammatory response, Hepatology, 48, 1632, 10.1002/hep.22519
De Giorgi, 2015, Long-term effects of roux-en-y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: a cross-sectional pilot study, Clin Nutr, 34, 911, 10.1016/j.clnu.2014.09.018
Kohli, 2015, Bile acid signaling: mechanism for bariatric surgery, cure for nash?, Dig Dis, 33, 440, 10.1159/000371699
Albaugh, 2015, Early increases in bile acids post roux-en-y gastric bypass are driven by insulin-sensitizing, secondary bile acids, J Clin Endocrinol Metab, 100, E1225, 10.1210/jc.2015-2467
Ryan, 2014, Fxr is a molecular target for the effects of vertical sleeve gastrectomy, Nature, 509, 183, 10.1038/nature13135
Rizzo, 2006, The farnesoid x receptor promotes adipocyte differentiation and regulates adipose cell function in vivo, Mol Pharmacol, 70, 1164, 10.1124/mol.106.023820
Abdelkarim, 2010, The farnesoid x receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the wnt/beta-catenin pathways, J Biol Chem, 285, 36759, 10.1074/jbc.M110.166231
Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450
Burcelin, 2016, Gut microbiota and immune crosstalk in metabolic disease, Mol Metab, 5, 771, 10.1016/j.molmet.2016.05.016
Zhao, 2018, Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes, Science, 359, 1151, 10.1126/science.aao5774
Chan, 2016, High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma a-fabp and cholesterol: a pilot study of high fat diet and its intervention with lactobacillus rhamnosus gg (lgg) or telmisartan in apoe-/- mice, BMC Microbiol, 16, 264, 10.1186/s12866-016-0883-4
Gao, 2009, Butyrate improves insulin sensitivity and increases energy expenditure in mice, Diabetes, 58, 1509, 10.2337/db08-1637
Kimura, 2013, The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor gpr43, Nat Commun, 4, 1829, 10.1038/ncomms2852
Tang, 2017, The gut microbiome and its role in cardiovascular diseases, Circulation, 135, 1008, 10.1161/CIRCULATIONAHA.116.024251
Kimura, 2014, The scfa receptor gpr43 and energy metabolism, Front Endocrinol, 5, 85, 10.3389/fendo.2014.00085
Vinolo, 2011, Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils, J Nutr Biochem, 22, 849, 10.1016/j.jnutbio.2010.07.009
Vinolo, 2012, Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice, Am J Physiol Endocrinol Metab, 303, E272, 10.1152/ajpendo.00053.2012
Kim, 2014, Gut microbiota-derived short-chain fatty acids, t cells, and inflammation, Immune Netw, 14, 277, 10.4110/in.2014.14.6.277
Asarat, 2015, Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells, Int J Food Sci Nutr, 66, 755, 10.3109/09637486.2015.1088935
Fabian, 2006, Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women, Ann Nutr Metab, 50, 387, 10.1159/000094304
Anderson, 1999, Effect of fermented milk (yogurt) containing lactobacillus acidophilus l1 on serum cholesterol in hypercholesterolemic humans, J Am Coll Nutr, 18, 43, 10.1080/07315724.1999.10718826
Pindjakova, 2017, Gut dysbiosis and adaptive immune response in diet-induced obesity vs. Systemic inflammation, Front Microbiol, 8, 1157, 10.3389/fmicb.2017.01157
Clarke, 2014, Minireview: gut microbiota: the neglected endocrine organ, Mol Endocrinol, 28, 1221, 10.1210/me.2014-1108
Thaiss, 2014, The interplay between the innate immune system and the microbiota, Curr Opin Immunol, 26, 41, 10.1016/j.coi.2013.10.016
Kato, 2014, The role of the adaptive immune system in regulation of gut microbiota, Immunol Rev, 260, 67, 10.1111/imr.12185
Honda, 2016, The microbiota in adaptive immune homeostasis and disease, Nature, 535, 75, 10.1038/nature18848
Ohira, 2013, Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages, J Atheroscler Thromb, 20, 425, 10.5551/jat.15065
Wang, 2015, Sodium butyrate alleviates adipocyte inflammation by inhibiting nlrp3 pathway, Sci Rep, 5, 12676, 10.1038/srep12676
Alemán, 2018, Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women, J Transl Med, 16, 244, 10.1186/s12967-018-1619-z
Janssens, 2003, Role of toll-like receptors in pathogen recognition, Clin Microbiol Rev, 16, 637, 10.1128/CMR.16.4.637-646.2003
Pineiro, 2008, Fao technical meeting on prebiotics, J Clin Gastroenterol, 42, S156, 10.1097/MCG.0b013e31817f184e
Ettinger, 2014, The influence of the human microbiome and probiotics on cardiovascular health, Gut Microbes, 5, 719, 10.4161/19490976.2014.983775
Kim, 2018, Probiotics, prebiotics, synbiotics and insulin sensitivity, Nutr Res Rev, 31, 35, 10.1017/S095442241700018X
Karamali, 2016, Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial, Diabetes Metab, 42, 234, 10.1016/j.diabet.2016.04.009
Crommen, 2017, Microbial regulation of glucose metabolism and insulin resistance, Genes, 9, 1, 10.3390/genes9010010
Yoo, 2013, Probiotics l. Plantarum and l. Curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity, Obesity, 21, 2571, 10.1002/oby.20428
Wang, 2015, Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice, ISME J, 9, 1, 10.1038/ismej.2014.99
Everard, 2013, Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc Natl Acad Sci USA, 110, 9066, 10.1073/pnas.1219451110
Mischke, 2018, Specific synbiotics in early life protect against diet-induced obesity in adult mice, Diabetes Obes Metab, 20, 1408, 10.1111/dom.13240
Aronsson, 2010, Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (angptl4), PLoS ONE, 5, e13087, 10.1371/journal.pone.0013087
Park, 2013, Supplementation of Lactobacillus curvatus hy7601 and Lactobacillus plantarum ky1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity, PLoS ONE, 8, e59470, 10.1371/journal.pone.0059470
Ukibe, 2015, Administration of lactobacillus gasseri sbt2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice, Br J Nutr, 114, 1180, 10.1017/S0007114515002627
Miyoshi, 2014, Anti-obesity effect of lactobacillus gasseri sbt2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice, Eur J Nutr, 53, 599, 10.1007/s00394-013-0568-9
Kadooka, 2010, Regulation of abdominal adiposity by probiotics (lactobacillus gasseri sbt2055) in adults with obese tendencies in a randomized controlled trial, Eur J Clin Nutr, 64, 636, 10.1038/ejcn.2010.19
Gibson, 1999, Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin, J Nutr, 129, 1438S, 10.1093/jn/129.7.1438S